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Anastomotic leakage
Anastomotic dehiscence is the most feared and potentially devastating complication 
after gastrointestinal surgery. Dehiscence, with a reported incidence varying between 
1 and 30% is attended by high morbidity while its mortality rate is believed to fall 
between 10 and 15%. 1-4 Thus, there is much to gain by the identification of its 
causes and the development of preventive measures.
Impairment of anastomotic healing is probably multifactorial. Many clinical 
studies have aimed to identify risk factors for impaired anastomotic healing 1;2;4-7 
but the evidence remains equivocal. The finding that anastomotic leakage takes 
place in the absence of any currently known risk factor, illustrates that much 
remains unknown. 8 Apparently, some anastomotic leaks are inevitable, despite 
proper caution and excellent surgical technique. 9 Leakage of intestinal anastomoses 
therefore remains the single most important hazard which can result in 
generalized peritonitis due to feacal spill into the abdominal cavity. Consequently, 
reoperation with or without dismantling of the failed anastomosis and the 
construction of a temporary ileo- or colostomy may be necessary. The patient has 
to deal with this challenge while still recovering from the initial operation. 
Protecting the anastomotic integrity and finding ways to minimize, postpone or 
prevent the consequences of leakage remain important goals of ongoing research.
Wound healing
Wound healing is an evolutionary conserved, complex, multi-cellular process that 
consist of a series of carefully regulated steps, which are initiated after disruption 
of the normal structure and function of tissue. The classic sequential, yet overlapping, 
phases of wound healing are inflammation, proliferation and remodeling. 10 
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The process involves the coordinated efforts of several cell types. The migration, 
infiltration, proliferation and differentiation of these cells will culminate in an 
inflammatory response and the formation of new tissue. This complex process is 
regulated by a signaling network involving numerous growth factors and cytokines. 11 
In the inflammation or latent phase platelets create hemostasis by formation of an 
insoluble fibrin clot. Inflammatory cells, mostly neutrophils are recruited to the 
wound site. Debris and bacteria are phagocytosed. Influx of neutrophils is followed 
by monocytes which differentiate into macrophages. After 2-3 days these regulatory 
cells predominate the infiltrate and release a multitude of tissue growth factors 
and proteolytic enzymes. 
Proteolytic degradation of the extracellular matrix, to remove damaged tissue and 
provisional matrix and to allow angiogenesis and cell migration, is an intrinsic 
feature of repair. Matrix metalloproteinases (MMPs), a family of proteolytic enzymes 
that degrade specific components of the extracellular matrix, play multiple roles 
in wound healing. 12 
Inflammation gradually resolves and the proliferation phase takes over from 
around day 4. In this phase new matrix is produced by fibroblasts which become 
the predominant cell type. Newly-formed collagen restores tissue strength. Once 
the collagen fibrils are formed they mature by formation of crosslinks and organize, 
resulting in increased wound strength. This process requires adequate oxygenation 
and nutrient supply provided by angiogenesis. 
During the last, remodeling or repair, phase cells eventually disappear and cell- 
rich granulation tissue becomes cell-poor scar tissue. Further reorganization of 
collagen fibers occurs.
 
Wound healing in the gastrointestinal tract
Most of the intestinal tract consist of four layers: mucosa, submucosa, muscularis 
(muscle layer) and serosa.
The strength of the intestinal wall is mainly derived from collagen fibrils located 
in the submucosal layer. When the intestinal tract is surgically disrupted and 
continuity is restored by construction of an anastomosis the repair process starts. 
It follows the general pattern of wound healing, which is essentially similar in all 
tissues, although there are some subtle differences. 8;13;14 Immediately after operation, 
the anastomosis is far weaker than the intact tissues. During the first days after 
surgery, in the inflammation phase, the anastomosis remains very weak. Upregulation 
of matrix metalloproteinase (MMP) activity may even result in further loss of 
strength. During this phase anastomotic strength depends solely on the suture 
holding capacity of the submucosal and muscular layers. After three days, new 
collagen is synthesized by fibroblasts but also by smooth muscle cells and new matrix 
starts to form. During the proliferation phase anastomotic strength increases 
consistently to pre-operative values. After seven days anastomotic strength may 
surpass that of the adjacent intact bowel wall. From the short description above it 
follows that the risk of wound failure in the intestinal tract is greatest during the 
earliest phase of the repair cascade. It seems logical to suppose that adverse 
conditions have most chance to disrupt the sutured intestinal wall before collagen 
accumulation and matrix deposition have restored initial strength.
Analgesia
Optimal management of postoperative pain remains a topic of ongoing research 
because it directly relates to postoperative patient well-being and clinical outcome. 
Peri-operative analgesia is ever increasing and expanding in patients after gastro-
intestinal surgery. Surprisingly, in the search for risk factors which contribute to 
anastomotic leakage little attention has been paid to the use of analgetic drugs. In 
addition, relatively little is known from preclinical studies about their potential 
effects on wound repair in general and anastomotic repair in particular. The 
cornerstones of perioperative pain relief are paracetamol, non steroidal anti-in-
flammatory drugs (NSAIDs) and opioids.
Paracetamol
Paracetamol, acetaminophen, is considered an effective analgetic and antipyretic 
drug, which is very often and quite routinely administered for perioperative pain 
relief, also after gastrointestinal surgery. It is not quite clear which analgesic 
pathway is affected by the administration of this non-opoid drug, but multisite 
activity in the central nervous system has been suggested. Potential mechanisms 
include interaction with both the serotonergic and cannabinoid pathways. 
However, an anti-inflammatory effect has also been reported through inhibition 
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tissue together. 31-34 Two frequently used seals are fibrin glue and fibrin-thrombin 
coated patch, which both consists of homologous plasma-derived fibrin products 
from pooled donors combined with bovine thrombin and mimic the final stages of 
blood coagulation and fibrin clot formation. Their benefits in the field of gastroin-
testinal surgery need to be established.  
Studying the intestinal anastomosis in the rat
Animal models are frequently used in experimental and preclinical studies. In 
order to study the fundamental processes of healing of the intestinal anastomosis 
rats are used almost routinely, far more frequently than mice, rabbits or bigger 
animals. Anastomotic healing in the rat is believed to essentially represent the 
human situation. Obviously, it must always be kept in mind that one should exert 
caution in translating results and conclusions drawn from such studies to the 
clinical situation. In our research laboratory we have gained broad experience 
using rats as a model for anastomotic healing. * 
The animals tolerate surgery and the construction of an anastomosis very well 
and measurement of the various parameters for repair are reproducible. 35;36 Next to 
macroscopic signs of anastomotic leakage like dehiscence of the anastomosis, the 
presence of faecal peritonitis, a puncture in the anastomotic line with or without an 
abscess near it, measurement of anastomotic strength constitutes the key parameter to 
assess healing. The latter can be measured as either resistance to intraluminal 
(bursting pressure) or longitudinal pressure (breaking strength). Both bursting 
pressure and breaking strength may be measured sequentially on the same 
segment 37 and are thus essentially independent parameters for wound strength. 
Next to these main outcome parameters biochemical parameters are also measured. 
Early wound strength depends on the capacity of the existing extracellular matrix 
to retain sutures and matrix strength is determined by the presence of collagen. 
As hydroxyproline is an rather unique component of collagen, hydroxyproline 
levels reflect the presence of collagen. Loosening or degradation of the matrix is 
believed to be mediated by MMPs, which enzymatic activities can also be measured. 
The gelatinases MMP-2 and MMP-9 have been shown to be upregulated in the 
healing anastomosis. 38-40  Finally, (semi) quantative histological analysis of cells 
and structures relevant to healing can be used to study the repair sequence in the 
rat intestine.
A model for anastomotic leakage
Next to unraveling the mechanism and risk factors of anastomotic leakage, the 
incidence of anastomotic dehiscence and the severity of its consequences ask for 
of cyclooxygenase (COX). 15-18 With the exception of a few studies on the muscoskeletal 
system, little has been reported on the potential effects op paracetamol on wound 
healing and no data are available at all pertaining to the healing of intestinal 
anastomoses.
Non-steroidal anti-inflammatory drugs (NSAIDs)
NSAIDs are often added to paracetamol therapy immediately after surgery or after 
cessitation of other analgetics such as epidural analgesia or patient controlled analgesia, 
usually around day 3 after surgery. NSAIDs inhibit cyclooxygenase enzymes, 
which catalyze the first two steps in prostanoid biosynthesis. Prostanoids influence 
inflammatory and immune responses, as well as sensitizing and augmenting the 
pain pathway. 19 COX enzymes occur as the isoforms COX-1 and COX-2. COX-1 is 
expressed constitutively in housekeeping functions, whereas COX-2 is expressed 
only in response to external stimuli and is postulated to be mainly involved in 
essentially pathological conditions such as inflammation, pain and fever. 20 The 
inflammatory reaction constitutes the first phase of wound healing and is an 
essential link within the wound repair cascade. Inhibitors of the COX enzymes 
might therefore interfere with inflammation and wound healing. Indeed, negative 
effects of NSAIDs (COX inhibitors) on anastomotic healing have already been 
described 21-25 but have not lead to changes in their clinical use. In fact in the 
Netherlands diclofenac and naproxen are frequently used NSAIDs used for pain 
relief immediately after intestinal (fast track) surgery.
Opioids
Paracetamol and NSAIDs decreases morphine consumption and therefore morphine-
related adverse effects like inhibition of the intestinal motility. 26  The influence of 
morphine on anastomotic healing has not been described. Chronic use of morphine 
treatment has been reported to inhibited early recruitment of both neutrophils 
and monocytes towards an inflammatory signal and suppresses angiogenesis in 
general wound healing. 27;28
Sealants
Reinforcement of the suture or staple line is one of the possible strategies to 
diminish the risk of perioperative complications. 29;30 Applying some kind of seal 
around the intestinal anastomosis to prevent feacal content from leaking into the 
abdominal cavity and causing peritonitis seems a logical way to contain the effects 
of dehiscence of the intestinal wound. Fibrin based sealants are increasingly used 
in different fields of surgery to provide a sealing barrier, hemostasis and bond 
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ways to protect anastomotic integrity, particularly if intestinal continuity needs 
to be restored in conditions which have been associated with high leakage rates. 
The development of such procedures requires preclinical evaluation and thus an 
animal model for anastomotic dehiscence. 
So far, the only known way to mimic a leaking anastomosis consists of the creation 
of an iatrogenic defect during its construction, mostly by using an insufficient 
number of sutures. 41-44
However, ideally, a complete and patent anastomosis should be constructed which 
develops dehiscence with time. Such a model would be less artificial and clinically 
more relevant and would offer an unique possibility for translational research. In 
particular, it would allow to investigate the efficacy of means to prevent leakage or 
contain or postpone its effects, such as peroperative application of biological 
sealants. To our knowledge, there is no such experimental model available.
Outline of the thesis
With respect to the problems and questions outlined above we have addressed the 
following aspects relevant to anastomotic repair in the intestine. All studies have 
been performed in the well-established rat model.
· Chapter 2: the effects of paracetamol on anastomotic healing in ileum, colon 
and abdominal fascia.
· Chapter 3: the effects of the NSAIDs naproxen and diclofenac on ileal and 
colonic anastomoses.
· Chapter 4: the effect of the NSAID carprofen on anastomotic healing in ileum 
and colon.
· Chapter 5: further characterization of the negative effects of carprofen on 
ileal healing.
· Chapter 6: the effects of application of fibrin glue to the anastomosis on the 
course of wound repair in ileum and colon.
· Chapter 7: the effects of fibrin glue and a fibrin coated patch around a high-risk 
anastomosis in the ileum.
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Abstract
Background Paracetamol is a cornerstone for peri-operative pain relief. Its mechanism 
of action may include a local anti-inflammatory effect with inhibition of cyclo-
oxygenase isoenzymes. The scarce literature available on its effects on wound 
healing consists of preclinical studies into the effect of paracetamol on healing of 
the musculoskeletal system. Although the drug is used abundantly for pain relief 
after surgery of the gastro-intestinal tract, there are no published data on the 
influence of paracetamol on anastomotic and abdominal healing. This also holds 
for the, crucial, early inflammatory phase of repair. The recovery of wound 
strength could therefore conceivably be affected by paracetamol.
Methods In 78 male Wistar rats an anastomosis was constructed in colon and 
ileum. The rats received either a low or a high dose (50 or 200 mg/kg/day, divided 
over two doses) paracetamol or vehicle (controls) until they were killed on day 3 or 
7 after surgery (n=13 each). In anastomoses, the main outcome parameters were 
two independent measures for wound strength, bursting pressure and breaking 
strength, the latter being the primary outcome parameter. In addition, collagen 
levels were measured and histology was performed. In fascia, breaking strength 
was analysed. 
Results No significant differences were found between control and paracetamol-
treated groups at any time point for any of the parameters. Wound strength 
increased significantly from day 3 to day 7 in all groups. In the colon anastomosis 
the breaking strength increased from 130 ± 9 g (mean ± SEM) at day 3 to 232 ± 17 g 
at day 7 in the control group, from 144 ± 10 to 224 ± 9 g in the low dose group and 
from 130 ± 12 to 263 ± 28 g in the high dose group. The lower limit for the 95% CI 
was -11 for the difference between control and low dose groups at day 3 and -25 for 
the difference between control and high dose groups. No differences in collagen 
levels were found between the high dose and control groups. Histology did not 
indicate the presence of gross differences between groups.
Conclusion Peri-operative use of paracetamol in a rat model of intestinal surgery 
does not significantly impede wound repair in the early postoperative period.
Introduction 
Optimal management of postoperative pain remains a topic of ongoing research 
because it directly relates to postoperative patient well-being and clinical outcome. 
1;2 Paracetamol, acetaminophen, is considered an effective analgetic and antipyretic 
drug that is a cornerstone in peri-operative pain relief, also in patients who have 
to go through intestinal surgery. Paracetamol decreases morphine consumption 
and therefore morphine-related adverse effects. 3 With the exception of a few 
studies on the muscoskeletal system, surprisingly little has been reported on the 
potential effects of paracetamol on wound healing. 
It is not quite clear which analgesic pathway is affected by the administration of 
this non-opoid drug, but multisite activity in the central nervous system has been 
suggested. Potential mechanisms include interaction with both the serotonergic 
and cannabinoid pathways. However, an anti-inflammatory effect has also been 
reported through inhibition of cyclooxygenase (COX) isoenzymes. 4-7 The inflammatory 
reaction constitutes the first phase of wound healing and is an essential link 
within the wound repair cascade. Inhibitors of the COX enzymes might interfere 
with inflammation and wound healing. Indeed, negative effects of NSAIDs (COX 
inhibitors) on anastomotic healing have already been described. 8-12
Although the drug is used abundantly for pain relief after surgery of the gastro-
intestinal tract, there are no published data on the influence of paracetamol on 
anastomotic and abdominal healing. This also holds for the, crucial, early inflammatory 
phase of repair. If paracetamol affects inflammation it conceivably could interfere 
with the recovery of wound strength. Therefore, we examined the effects of 
paracetamol on early healing in ileum and colon anastomoses and the abdominal 
wall of the rat.
Methods 
Study Design
Seventy eight male Wistar rats (Harlan BV, Horst, The Netherlands) were housed 2 
per cage and accustomed to laboratory conditions for five days before the start of 
the experiment. They were randomly divided over three groups of 26 animals 
each, one control group and two experimental groups. At day 0 all rats underwent 
intestinal resection and anastomoses were constructed in both colon and ileum. 
The two experimental groups received different doses (low and high) of paracetamol 
daily from operation onwards. Rats were observed closely and weighed daily and 
had free access to water and standard rodent chow (Hope Farms, Woerden, The 
Netherlands) throughout the entire experimental period. Half of the rats within 
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Segments of 2 cm length, containing the anastomoses in the middle, were resected 
with sutures left in place. The segments were placed over a plastic tube and secured 
with a vessel loop on one end and closed with a clamp on the other side. To measure 
bursting pressure, the segments were infused (2 ml/min) with 0.9% NaCl containing 
methylene blue. The maximum pressure (mmHg) recorded immediately before 
sudden loss of pressure was taken as the bursting pressure. The site of rupture 
(within or outside the anastomotic line) was noted. Subsequently, the same segments 
were placed in a tensiometer, and the breaking strength (g) was measured. 13 
A rectangle (approximately 1 x 2 cm) containing the laparotomy wound in the 
middle was carefully cut out from the abdominal wall. After removing the 
running suture the segment was cut in half to create two samples with the midline 
laparotomy wound in the middle. The length of the laparotomy wound in each 
sample was noted before it was placed in the tensiometer. Subsequently, the 
breaking strength was measured and expressed in g/mm tissue by using the mean 
value obtained from both measurements.
The anastomotic segments and abdominal wall were carefully cleaned from any 
adhering tissue and 5 mm samples, containing the suture line in the middle, were 
frozen in liquid nitrogen and stored at -80 °C until further processing. 
Biochemical analysis
After weighing, tissue samples were frozen, lyophilized and pulverized. The 
hydroxyproline content, as a measure of the collagen content, was measured in 
the control and high dose groups by high-performance liquid chromatography 
(HPLC) after hydrolysis with 6 N hydrochloric acid and coupling to dabsyl-chloride. 
The detection limit of the assay is 0.25 μg and intra assay and inter assay coefficients 
of variation (at 6 μg levels) are 2.3 % and 10.3 %, respectively. In animals killed at 
day 7 blood was collected 1 h after the last gift of paracetamol (or vehicle) and 
immediately prior to killing the animals. Paracetamol levels were measured in 
heparin plasma by the Cobas Integra® (Roche) system. Detection limit is 0.2 mg/l. 
Histology
The remaining 14 animals (Table 1) were killed as described above and used for 
descriptive histology. Intestinal samples of approximately 1 cm containing the 
entire anastomosis in the middle were carefully collected en bloc, opened at the 
mesenteric side, washed gently in 0.9% and spread out in a cassette for paraffin-
embedding. From paraffin-embedded tissues, 4 μm sections were prepared and 
stained with hematoxylin and eosin (H&E).  Sections were analyzed by using a 
binocular light microscope.
each group were killed at day 3 and day 7 after operation (Table 1). The Animal 
Ethics Review Committee of the Radboud University Nijmegen approved the study. 
The study was conducted in a manner that does not inflict unnecessary pain or 
discomfort upon the animal, as outlined by the United States Public Health Service 
Policy on Humane Care and Use of Laboratory Animals and the Guide for the Care 
and Use of Laboratory Animals (1996), prepared by the National Academy of 
Sciences Institute for Laboratory Animal Research. 
Surgery and analgesics
Procedures were performed under semi sterile conditions using a Zeiss operation 
microscope (Carl Zeiss AG, Oberkochen, Germany). Animals were anesthetized by 
use of a mixture of isoflurane, oxygen and nitrogen, while breathing spontaneously 
through a mask. A midline laparotomy was performed and in each rat a 1-cm 
segment was resected from the descending colon 3 cm proximal to the peritoneal 
reflection. Colonic continuity was restored by constructing an end-to-end anastomosis 
with 8 single-layer, inverting, interrupted sutures (Ethilon 8-0; Ethicon, Norderstedt, 
Germany).  A similar procedure was performed in the distal ileum, 15 cm proximal 
to the cecum. The abdominal wall was closed with a running suture (Vicryl 3-0; 
Ethicon, Norderstedt, Germany). The skin was closed with staples. During operations, 
body temperature was kept at 38°C using a heating pad and a lamp. Intestines 
were covered with gauze pads soaked with 0.9% NaCl to minimize desiccation. To 
prevent dehydration, 10 ml of 0.9% NaCl was administered subcutaneously after 
the operation. 
All rats were administered buprenorphine (Temgesic, Schering Plough, Houten, 
the Netherlands), 0.02 mg/kg subcutaneously, every 12 hours (5 times in total) for 
48 hours, the first dose just prior to surgery. The first experimental group received 
acetominophen (Paracetamol, Sigma-Aldrich Chemistry, Steinhem, Germany) in a 
dose of 50 mg per kg each day (low dose) by oral gavage. The daily dose was divided 
in two parts which were given at least eight hours apart during the experimental 
period and starting just prior to surgery. The second experimental group (high 
dose) was given 200 mg/kg paracetamol per day. Paracetamol was dissolved in 0.5 
ml 0.9% NaCl and 0.1% polysorbate 20 (Tween 20, Fluka Chemika, Buchs, 
Switserland), the control group received 0.5 ml of this solution (vehicle) per gavage 
twice a day.
Necropsy and analysis of wound strength
Ten rats from each group were killed by CO/CO
2
 asphyxiation on postoperative day 
3. (Table 1)  At day 7, another 10 rats were killed for wound strength analysis by 
cardiac puncture and cervical dislocation, in order to allow blood sampling (see 
below). Adhesions were dissected carefully without manipulation of the anastomosis. 
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Statistics
Historical data from our own group show the breaking strength of colonic 
anastomoses at day 3 typically to be 117 ± 27 (SD) g. 10;14 Sample size was determined 
as sufficient to detect a loss of wound strength of 30 g (25 %). Using an α of 0.05, a 
power of 0.8 and an one-tail test the group size is calculated (G*Power 3.1.2) to be 
10 (actual power 0.84).
All data passed the normality test (Kolmogorov-Smirnov,  p>0.10). Comparison 
between control and both experimental groups was  performed using a One-way 
Analysis of Variance (ANOVA). Comparisons between two groups (hydroxyproline 
content) or, within one group, between values at two different days were performed 
with a one-tailed unpaired t-test. The lower limit of the (one-sided) 95% confidence 
interval (CI) for the difference between each of the 2 paracetamol groups and the 
control group  was determined using a t-test, with Fisher LSD procedure. (see Table 1 
of Hayter, 1986)  Results were considered statistically significant at p<0.05.
Results
General observations and paracetamol plasma concentrations
Four animals died prematurely. One animal from the low dose group did not 
survive the surgery. Two animals (one from the control group and one from the 
high dose group) were taken out of the experiment because of extreme weight loss 
and poor clinical condition. Both showed signs of ileus at obduction, but the 
anastomoses were all intact and conductant. One animal from the low dose group 
died from self mutilation on day 2 (Table 1). 
At operation the rats weighed between 250 and 295 g (average 286 g) without 
differences between groups. All animals experienced transient postoperative weight 
loss which was maximal at day 3-4 and averaged approximately  9 % in all groups. 
At day 7 the mean (± SEM) relative body weight (compared to the preoperative 
weight) was 98 ± 1.2 %, 95 ± 2.1 % and 97 ± 0.9 % in controls, low dose and high dose 
groups, respectively. There were no signs of wound dehiscence of the laparotomy 
wound. No macroscopic signs of anastomostic leakage were found. Paracetamol levels 
were determined in plasma collected on day 7 one hour after drug administration. 
Average values (n=4, ± SEM) were 0 ± 0 mg/l,  0.4 ± 0.4 mg/l  and 22.7± 6.5 mg/l in the 
controls and low and high dose groups, respectively.
Wound strength
In the control and both paracetamol groups the anastomotic bursting pressure 
remained low after 3 days and increased sharply (p<0.0001, both in ileum and in 
colon) thereafter (Figure 1). At day 7, in all groups, the bursting site had shifted 
2
Table 1  Experimental groups
Control  Low dose High dose 
Operated at day 0 26 26 26
Premature death (day) 1 (2) 2 (0,2) 1 (2) 
Terminated at day 3 for 
biochemical analysis
10 10 10
Terminated at day 3 for 
histological analysis
3 3 3
Terminated at day 7 for 
biochemical analysis
10 10 10
Terminated at day 7 for 
histological analysis
2 1 2
Number of animals operated on day 0 and premature deaths. At day 3 and 7 10 animals in each group 
were analyzed for wound strength and the remaining animals for histology.
Figure 1  Anastomotic bursting pressure. Individual values and means (horizontal 
bars) are given for ileal (A) and colonic (B) anastomoses in both control (C)  low dose 
(L) and high dose (H) groups. The bursting site was either within ( ) or outside ( ) the 
suture line.
0 
50 
100 
150 
200 
250 
300 
350 
400 
450 
0 
50 
100 
150 
200 
250 
300 
350 
400 
450 
A 
B 
B
u
rs
ti
n
g 
p
re
ss
u
re
 (m
m
H
g)
 
C L H C L H
day 3 day 7
26 27
On day 3, the strength of the abdominal fascia was only just measurable and varied 
widely between groups, e.g. 3,2 ± 0.7 g/mm in controls and 1,9 ± 0,5 and 4,8 ± 2,4 g/mm 
in low dose and high dose groups, respectively. In all groups, it increased manyfold 
(p<0.0001) until day 7 where control values averaged 87 ± 10 g/mm (Figure 2C). 
Paracetamol treatment did not affect wound breaking strength in any consistent or 
dose-dependent way: no significant differences (ANOVA) were found between control, 
low and high dose groups on either day. Table 2 shows average values together with 
the lower limit of the 95% CI for the difference between controls and paracetamol-
treated groups, demonstrating that the probability for true loss of strength is quite 
limited.
Collagen and  histology
Hydroxyproline levels were measured in anastomotic samples from the control 
and high dose groups. In both groups, the hydroxyproline content, expressed as 
μg/5 mm, increased significantly (p<0.05) from day 3 to day 7 (Figure 3). There was 
no significant difference between groups on day 3 or day 7, neither in the ileum 
nor in the colon. The same was true for the wound hydroxyproline concentrations, 
expressed as μg/mg dry weight (data not shown). 
Although the number of animals available for histological analysis was limited, 
no gross differences between paracetamol treated rats and control rats were 
observed in the architecture of either the anastomosis in ileum and colon or the 
abdominal wound (not shown). Figure 4 illustrates normal healing and closing of 
the mucosal gap in the ileum between day 3 and 7 after surgery in the control and 
high dosed animals.
away from the suture line in most animals (Figure 1). Only in the ileum at day 3, 
the average values in the paracetamol treated animals, 44 ± 6 (mean ± SEM) and 51 
± 7 mm Hg for the low and high dose groups, remained below that in the controls 
(73 ± 11 mm Hg), but this effect was non-significant (p=0.06, ANOVA).  While 
measuring the breaking strength, tearing always occurred within the suture line. 
The increase in anastomotic breaking strength from day 3 to day 7 was also clear 
and significant (p<0.05 in ileum; p<0.0001 in colon) in all three groups (Figure 2A, B).  2
Figure 2  Wound breaking strength. Individual values and means (horizontal bars) 
are given for ileal (A) and colonic (B) anastomoses in control (C) and low dose (L) and 
high dose (H) groups. Panel C shows data for abdominal wounds, day 3 left y-axis 
and day 7 right y-axis.  
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Table 2  Wound breaking strength
Control Low dose High dose
Mean Mean 95% CI * Mean 95% CI *
Colon day 3 130 144 -11 130 -25
day 7 232 224 -54 263 -16
Ileum day 3 59 47 -31 54 -25
day 7 92 109 -8 98 -19
Abdomen day 3 3.2 1.9 -4.9 4.8 -2
day 7 87 87 -28 91 -23
Data represent mean values in the anastomoses (g) and abdominal wall (g/mm). * represents the lower 
limit of the (one-sided) 95% confidence interval for the difference between each of the paracetamol 
groups and the control group (t-test, Fisher LSD procedure).
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Discussion
Paracetamol does not have a detrimental effect on the strength of the healing intestinal 
anastomosis in the ileum or colon of the rat within the first seven days after operation. 
Also the strength of the abdominal fascia is not compromised by paracetamol.
The main outcome parameters to assess anastomotic healing in the intestine relate 
to mechanical strength. While the bursting pressure is a measure of the capacity 
to withstand intraluminal pressures the breaking strength represents longitudinal 
strength. Both can be measured sequentially on the same segment 13 and are thus 
essentially independent parameters for wound strength. Since the breaking 
strength always represented the true strength of the suture line (while at day 7 the 
bursting site was often outside the wound area) it is considered to be the primary 
outcome parameter.
The first days after operation wound strength remains low and chances for 
dehiscence are believed to be highest. From 3 days onwards collagen deposition 
increases and therefore wound strength increases. Thus, the first postoperative 
week is most crucial to undisturbed healing and therefore measuring points were 
set at day 3, when anastomotic strength is lowest, and day 7, where strength should 
be considerably elevated.
Wound breaking strength, as the primary outcome parameter, did not change in 
any consistent or dose-dependent way by the administration of paracetamol. No 
significant differences existed between groups and analysis of the 95% CI for 
differences between control and paracetamol treated groups (Table 2) demonstrated 
the probability for considerable, and possibly clinically relevant, loss of strength to 
be very low. Although at day 3 the average bursting pressure in the ileum was 
below that of the controls in both paracetamol treated groups, this effect remained 
non-significant. Moreover, the bursting pressure increased sharply thereafter. 
Altogether, analysis of the parameters for wound strength and collagen levels in 
anastomoses and abdominal wounds did not reveal any differences, even when 
paracetamol was given at a high dose. 
The scarce literature available consists of studies describing the effect of paracetamol 
on healing of tissues such as alveolar bone 15, femur 16, ligament 17 or the patellar 
tendon. 18 Here, paracetamol was given once a day or through the chow, while we 
divided the daily dose in two parts which were given at least 8 h apart. More 
importantly, the studies mentioned above examine repair at least 14 days after 
operation when the inflammatory phase of healing should long be over. For that 
reason, we studied parameters for repair at day 3, characterized by low wound 
strength during the inflammatory phase, and at day 7, characterized by increasing 
strength during the early proliferative phase. Presumably, wounds are most 
sensitive to disruption as their mechanical strength is lowest.
2
Figure 3  Hydroxyproline content of anastomotic segment.  Bars represent mean 
and SEM in ileal and colonic segments from the control groups (grey bars) and 
the groups which received a high dose of paracetamol (white bars) on day 3 and 7. 
Asterix denote significant (p<0.05) difference between values obtained at day 3 and 
day 7 within the same group.
Figure 4  Anastomotic histology in the ileum. Each panel shows a tissue segment 
with the anastomosis in the middle and the mucosal layer at the bottom at a 
magnification of approximately x 40, representing typical examples obtained in 
the control group at day 3 (A) and day 7(B) and in the high dose group at day 3 (C) 
and day 7(D). In each figure an arrow identifies a typical finding. In A the mucosal 
villi of the intestine is pointed out. In B a suture is marked. In C the inflammation, 
shaped as a triangle, is marked. Note that is fills in the anastomosis. In D the submucosal 
muscular layer of the intestine is marked.
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Although the minimum plasma paracetamol level required for analgesia is believed 
to be 10-20 mg/l 5;6, the concentrations measured in humans 80 min after 1 g oral 
paracetamol were substantially lower and demonstrated to range between 0 and 
13 (median 5) mg/l. 19 The low dosed rats were administered 50 mg/kg of paracetamol 
a day, which compares on a per-weight basis with the maximum recommended 
human dose of 4 g. This dosage  is based on  studies examining the effect of 
paracetamol on wound healing and dose-related effect on hyperalgesia in the rat. 
16-18;20 Some studies on other processes in rodents 21-24, although fairly dated, report 
a weak anti-inflammatory effect with higher doses of paracetamol. 
The group receiving 200 mg/kg of paracetamol a day was therefore included to 
ensure any  possible effect on wound healing would be noticed, even if it occurred 
after administration of supranormal dosages. Plasma concentrations in this group 
were comparable to those found after 2 g orally given to patients. 19 
The mechanism behind the suggested anti-inflammatory effect of paracetamol 
remains speculative. Paracetamol has periodically been proposed to inhibit one or 
more of the cyclooxygenase enzymes COX-1 and COX-2. 4;21;25 COX enzymes catalyse 
conversion of arachidonic acid to prostanoids involved in inflammation. However, 
paracetamol generally lacks the other local effects of NSAIDs on platelet 
aggregation and gastric mucous production. This could be explained if paracetamol 
acts only centrally, and not peripherally, as a COX inhibitor. 26 Perhaps this is why 
paracetamol does not influence the peripherally located processes of anastomotic 
and abdominal wall healing.
Anastomotic leakage remains a  feared and potentially devastating complication 
after gastrointestinal surgery. A leaking anastomosis is associated with increased 
morbidity and considerable mortality. 27;28 Many clinical studies have aimed to 
identify risk factors for impaired anastomotic healing, but so far very little 
attention has been paid to the use of analgetic drugs. The finding that anastomotic 
leakage takes place in the absence of any currently known risk factor, illustrates 
that much remains unknown. 29 Since paracetamol is widely prescribed to patients 
who need construction of an intestinal anastomosis, there should be no doubt as 
to its safety regarding the development of anastomotic strength. The present 
report supplies the first preclinical data which demonstrate that the peri-operative 
use of paracetamol does not affect the progression of wound repair in the intestine 
or the abdominal wall in its most crucial early postoperative period. 
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Abstract
Background Non steroid anti-inflammatory drugs (NSAIDs) such as the cyclooxygenase 
isoenzyme inhibitors diclofenac and naproxen are increasingly used for perioperative 
pain relief, while their potential effects on wound healing are scarcely investigated. 
Methods In 104 male Wistar rats an anastomosis was constructed in both colon 
and ileum. The rats were divided into groups who received diclofenac (4 mg/kg/
day) or naproxen (10 mg/kg/day) daily from the day of surgery or from day 3 after 
surgery. Animals were killed on day 3 or 7 and analysed for signs of anastomotic 
dehiscence and wound strength of anastomoses and abdominal fascia.
Results Anastomotic leakage in the ileum (p<0.0001) and mortality rates (p=0.001) 
were significantly increased in the diclofenac group. On day 7 the anastomotic 
bursting pressure in the ileum remained below that of the controls in the diclofenac 
and naproxen treated rats. When administration of diclofenac was postponed to day 3 
after surgery, anastomotic dehiscence was almost absent. The colonic anastomosis 
and abdominal wall always remained unaffected.
Conclusion This study implies that immediate postoperative administration of 
diclofenac and, to a far lesser extent, naproxen can affect healing in the ileal 
anastomosis in the rat. This negative effect can be prevented by a short postoperative 
delay in administration. Non steroid anti-inflammatory drugs such as the cyclo-
oxygenase isoenzyme inhibitors diclofenac and naproxen are increasingly used for 
perioperative pain relief, while their potential effects on wound healing are scarcely 
investigated. 
Introduction 
Non steroidal anti-inflammatory drugs (NSAIDs) are cornerstones in peri-operative 
pain relief because of their analgetic and anti-inflammatory features. NSAIDs 
decrease morphine consumption and therefore morphine-related adverse effects. 1 
NSAIDs  inhibit cyclo-oxygenase (COX) enzymes, which catalyze the first two steps 
in prostanoid biosynthesis. These enzymes occur as isoforms COX-1 and COX-2. 
COX-1 is expressed constitutively in different cells and tissues, whereas COX-2 is 
expressed mainly in response to external stimuli and is postulated to be involved 
in essentially pathological conditions such as inflammation, pain and fever. 2 
Selective inhibitors of COX-2 supposedly allow specific targeting of inflammatory 
disease processes, without disruption of normal homeostatic mechanisms that 
account for side-effects of non-selective NSAID therapy. While the potency and 
selectivity of the various NSAIDs available vary widely, even a selective COX-2 
inhibitor may also inhibit COX-1 to some extent, depending on its dosage.
Anastomotic dehiscence is the most feared complication after gastro-intestinal 
surgery. It is attended by high morbidity with a reported incidence varying between 
1 and 30% 3-7, while its mortality rate is believed to fall between 10 and 15%. 3;4;8-10 
Any factors interfering with early anastomotic repair might increase the chances 
for dehiscence. Many of the patients who undergo gastro-intestinal surgery, receive 
NSAIDs for pain relief in the early postoperative period. If COX inhibitors interfere 
with inflammation they might also affect wound healing, since the inflammatory 
reaction constitutes the first, essential phase of the wound repair sequence. Indeed, 
negative effects of different NSAIDs on anastomotic healing have already been 
described. 11-14 
In the Netherlands diclofenac and naproxen are the NSAIDs most frequently used 
for pain relief immediately after intestinal (fast track) surgery. Sometimes they are 
administered after cessation of other analgetics such as epidural analgesia or 
patient controlled analgesia, usually around day 3 after surgery. Incidental and 
conflicting preclinical data have been published on the effects of diclofenac on 
intestinal repair 11;15;16 while data for naproxen are completely lacking. This study 
aims to comprehensively describe the effects of diclofenac and naproxen on early 
healing of anastomoses in the ileum and colon and abdominal wounds in the rat. 
Methods 
Study Design
Hundred and four male Wistar rats weighing 250-295 g (Charles River, Sulzfeld, 
Germany) were housed 2 per cage and accustomed to laboratory conditions for 5 
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and starting immediately prior to surgery. The control rats received 0.5 ml vehicle 
per gavage twice a day. Rats that were administered diclofenac or naproxen delay 
received 0.5 ml of vehicle from operation up to day 3 when they switched to the 
drug regimen.
Necropsy and analysis of wound strength
The rats were killed by CO/CO
2
 asphyxiation on postoperative day 3 or day 7 
respectively. 
The abdomen was inspected and in particular attention was paid to signs of 
anastomotic leakage such as macroscopic dehiscence of the anastomosis, the 
presence of faecal peritonitis, a puncture in the anastomotic line with or without 
an abscess near it. Adhesions were dissected carefully without manipulation of the 
anastomosis. Segments containing the anastomoses were resected. To measure 
bursting pressure, the segments were infused (2 ml/min) with 0.9% NaCl containing 
methylene blue. The maximum pressure (mmHg) recorded immediately before 
sudden loss of pressure was taken as the bursting pressure. The site of rupture 
(within or outside the anastomotic line) was noted. 
Subsequently, the same segments were placed in a tensiometer, and the breaking 
strength (g) was measured. 17 A rectangle containing the laparotomy wound in the 
middle was carefully cut out from the abdominal wall. After removing the 
running suture the segment was cut in half to create two samples with the midline 
laparotomy wound in the middle. The length of the laparotomy wound in each 
sample was noted before it was placed in the tensiometer. Subsequently, the 
breaking strength was measured and expressed in g/mm tissue by using the mean 
value obtained from both measurements.  
The anastomotic segments and abdominal wall were carefully cleaned from any 
adhering tissue and 5 mm samples, containing the suture line in the middle, were 
frozen in liquid nitrogen and stored at -80 °C until further processing.
Biochemical analysis
After weighing, tissue samples were frozen, lyophilized and pulverized. The hydro-
xyproline content, as a measure of the collagen content, was measured by high-
performance liquid chromatography (HPLC) after hydrolysis with 6 N hydrochloric 
acid and coupling to dabsyl-chloride.
Preparation of tissue extracts for gelatin zymography, using a buffer containing 
1% (v/v) Triton X-100, has been described elsewhere. 18 The protein concentration of 
the extracts was measured using the bicinchoninic acid reagent. All tissue samples 
were stored at −80°C until zymography. The technique of preparation and electro-
phoresis of the gels and quantification of both the active and latent forms of 
gelatinases ((pro-)MMP-2 and (pro)MMP-9), which were expressed as arbitrary units 
days before the start of the experiment. They were randomly divided over 5 groups, 
a control group (C, n=24) and 4 experimental groups: a diclofenac group (D, n=28), 
a naproxen group (N,  n=28) and 2 groups in which the administration of the 
COX-inhibitor was delayed until the 3th day after surgery, the diclofenac delay (Dd, 
n=12) and naproxen delay (Nd, n=12) groups, respectively. The rats in the control, 
diclofenac and naproxen groups were scheduled to be killed on day 3 (10 in the C 
group and 12 in the D and N groups each) or day 7 (14 in the C group and 16 in the 
D and N groups each) after surgery, while all rats in de diclofenac delay and 
naproxen delay groups were scheduled for termination at day 7. The calculation of 
group size is given below.
All rats underwent intestinal resection and anastomoses were constructed in both 
colon and ileum. Rats were observed and weighed daily and had free access to water 
and standard rodent chow (Hope Farms, Woerden, The Netherlands) throughout 
the entire experimental period. The Animal Ethics Review Committee of the Radboud 
University Nijmegen approved the study.
Surgery and analgesics
Procedures were performed under semi sterile conditions using a Zeiss operation 
microscope (Carl Zeiss AG, Oberkochen, Germany). Animals were anesthetized by 
use of a mixture of isoflurane, oxygen and nitrogen, while breathing spontaneously 
through a mask. 
A midline laparotomy was performed and in each rat a 1-cm segment was resected 
from the descending colon 3 cm proximal to the peritoneal reflection. Colonic 
continuity was restored by constructing an end-to-end anastomosis with 8 single- 
layer, inverting, interrupted sutures (Ethilon 8-0; Ethicon, Norderstedt, Germany). 
A similar procedure was performed in the distal ileum, 15 cm proximal to the 
cecum. The abdominal wall was closed with a running suture (Vicryl 3-0; Ethicon, 
Norderstedt, Germany). The skin was closed with staples. During operations, body 
temperature was kept at 38°C using a heating pad and a lamp. Intestines were 
covered with gauze pads soaked with 0.9% NaCl to minimize desiccation. To 
prevent dehydration, 10 ml of 0.9% NaCl was administered subcutaneously after 
the operation. 
All rats were administered buprenorphine (Temgesic, Schering Plough, Houten, 
the Netherlands), 0.02 mg/kg subcutaneously, every 12 hours (5 times in total) for 
48 hours, the first dose just prior to surgery. Diclofenac (Diclofenac (sodium salt) 
Cayman Chemical Company An Arbor, MI, USA) was given in a dose of 4 mg/kg a 
day and naproxen (Naproxen sodium, Sigma Aldrich Chemie, Steinheim, Germany) 
in a dose of 10 mg/kg a day, both by oral gavage. The daily dose was divided into 
two parts which were administered (in a volume of 0.5 ml and dissolved in 0.1% 
polysorbate in saline) at least eight hours apart during the experimental period 
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different days were performed with a one-tailed unpaired t-test. Results were 
considered statistically significant at p<0.05.
Results
Clinical observations and mortality
Seven animals in the diclofenac group died prematurely of dehiscence of the ileal 
anastomosis, significantly more so than in the control group (Table 1). Also, signs 
of anastomotic leakage were far more frequent (p<0.0001) in the diclofenac group. 
In the naproxen group only 1 animal died and four animals showed signs of 
anastomotic leakage. In the diclofenac delay group one rat died of ileal dehiscence 
on day 6, while no animals died in the naproxen delay group. In the latter groups 
no further signs of anastomotic leakage were observed. 
All animals experienced transient weight loss after operation. In controls, weight 
loss was maximal at day 3, while the animals in the diclofenac and naproxen 
groups lost some more weight afterwards. As a consequence, there was a significant 
(p<0.05, ANOVA) difference between groups from day 4 onwards (Figure 1). Post- 
tests revealed no difference between controls and groups where drug administration 
was delayed.
on the basis of the lysed area, using a Sharp Jx-330 scanner and Imagemaster 1D 
software (Amersham Pharmacia, Uppsala, Sweden) has been described previously. 18 
Histology
The remaining 4 animals in the N, D and C groups on day 7 were killed as described 
above and used for histological observation. Intestinal samples of approximately 1 
cm containing the entire anastomosis in the middle were carefully collected en 
bloc, opened at the mesenteric side, washed gently in 0.9% and spread out in a 
cassette for paraffin-embedding. From paraffin-embedded tissues, 4 μm sections 
were prepared and stained with hematoxylin and eosin (H&E). Sections were 
analyzed by using a binocular light microscope.
The presence of COX-1 and COX-2 protein in healing anastomoses was visualized by 
immunohistochemistry.  From the paraffin-embedded tissues 4 μm sections were 
prepared and stained with COX-1 and COX-2 antibodies as described previously. 14 
After dewaxing, endogenous peroxidase activity was blocked with 3% H
2
O
2
 in 
 phosphate-buffered saline. Antigen retrieval was performed by heating the sections in 
a citrate buffered solution. After preincubation with 20 % normal goat serum, the 
sections were incubated overnight with a 1:1000 dilution of COX-1 or COX-2 antibody 
(rabbit polyclonal antiserum against human COX-1 and COX-2, Cayman Chemical, 
An Arbor, MI, USA). Subsequently, sections were incubated with a 1:200 dilution of 
goat anti-rabbit biotynilated secondary antibody. Following incubation with 
avidin–biotin complex, protein was visualized with diaminobenzidine. Sections 
were counterstained with haematoxylin. Another set of longitudinal sections from 
the control, diclofenac and naproxen group were stained with picrosirius red to 
identify collagen fibers in the anastomotic area collagen was quantified by digital 
image analysis. 19
Statistics and group size
Sample size was determined in order to detect a loss of wound strength of 25 %. 
Historical data from our own group show the breaking strength of colonic 
anastomoses at day 3 typically to be 117 ± 27 (SD) g and 232 ± 57 (SD) g at day 7 in 
the control groups. Using an α of 0.05, a power of 0.8 an a one-tail test the group 
size is calculated (G*Power 3.1.2) to be 10 (actual power 0.81).  To compensate for an 
expected mortality rate of 15% in rats that are administered a COX-2 inhibitor we 
added 2 animals to the four experimental groups. Furthermore we added 4 
animals per group in the C, D and N groups to examine histology at day 7. 
Comparison between control and several experimental groups was performed 
using a One-way Analysis of Variance (ANOVA) followed by a Tukey-Kramer post 
test. Comparisons between 2 groups or, within one group, between values at 2 
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Table 1  Mortality and anastomotic leakage
Number of rats Anastomotic 
leakage ileum
Premature 
death
Day of death
Control (C) 24 0 0
Diclofenac (D) 28 19 * 7 #   3 3 4 5 5 6 6  
Naproxen (N) 28 4 1 3
Diclofenac 
delay (Dd) 
12 1 1 6
Naproxen delay 
(Nd) 
12 0 0
Differences between the experimental groups and the control group were analysed for significance 
using Fisher’s exact test: * p < 0.0001 and # p = 0.0114.
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significance (ANOVA: p=0.049), without any significant differences between any of 
the groups after pair-wise post-testing. 
Analysis of the anastomotic breaking strength (figure 3) revealed a significant gain 
in strength between day 3 and day 7 and an absence of differences between groups, 
both at day 3 and day 7 in either ileum or colon. Finally, the strength of the 
abdominal fascia was very low 3 days after operation and increased manyfold 
afterwards, in a similar fashion in control, diclofenac and naproxen groups. Delay 
of drug administration did not lead to enhanced strength (Figure 4). 
Biochemical analysis
Collagen quantification and gelatin zymography were only performed in ileal 
anastomoses because the colonic anastomoses did not display any significant 
difference in wound strength between groups (see above). Hydroxyproline levels 
were measured in ileal anastomotic samples from the control, diclofenac and 
naproxen treated rats. The hydroxyproline content, expressed as μg/5 mm, increased 
Wound strength
On day 3 the mean bursting pressure in the ileum anastomoses was lower in the 
diclofenac group,  49 ± 10 (SEM) mm Hg, than in the control and naproxen groups, 
which were 61 ± 6 and 61 ± 9 mm Hg, respectively (ANOVA: ns). On day 7 bursting 
pressures had risen considerably and significantly in these three groups (diclofenac 
group 215 ± 73 mm Hg, control group 311 ± 11 mm Hg and naproxen group 233 ±24 
mm Hg), but only four animals remained in the diclofenac group. If values for the 
control, diclofenac and naproxen groups were analysed by ANOVA differences 
were nearly significant  (p=0.067), due to the fact that the mean value in the 
diclofenac group was lower than in the others. If all groups, including those where 
drugs were withheld until day 3, were analysed by ANOVA the p-value was 0.0009. 
Post-testing demonstrated significantly (p<0.05) higher values in the diclofenac 
(337 ± 11 mmHg) and naproxen delay (334 ± 16 mm Hg) groups than in the groups 
where drugs were started at the day of operation (Figure 2a). 
The average bursting pressure of the colonic anastomosis at day 3 was 66 ± 3, 78 ± 
9 and 63 ± 8 mm Hg in the control, diclofenac and naproxen groups, respectively 
(not significantly different). At day 7 the bursting pressure had risen to 199 ± 12, 
249 ± 8 and 154 ± 25 mm Hg in the control, diclofenac and naproxen groups, 
respectively, and was 242 ± 13 and 193 ± 28 mm Hg  in the diclofenac and naproxen 
delay groups (figure 2b). Comparison between the five groups together demonstrated 
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Figure 1  Postoperative course of body weight. Points represent mean values for 
body weight as percentage of pre-operative weight. *, p<0.05 by ANOVA.
Figure 2  Anastomotic bursting pressure. Individual values and means (horizontal 
bars) are given for ileal (a) and colonic (b) anastomoses in control (C), diclofenac 
(D), naproxen (N) and the diclofenac and naproxen delay (Dd and Nd) groups. 
The bursting site was either within ( ) or outside ( ) the suture line. * or #, p<0.05 
vs D and N group, respectively.
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Gelatin zymography of extracts from 3 days old ileal anastomoses demonstrated 
the presence of various forms of matrix metalloproteinase MMP-2 and MMP-9. 
Highest total activities, expressed in arbitrary units/5 mm tissue, were found for 
proMMP-9. While mean values were higher in diclofenac and naproxen groups, 
563 ± 62 (in arbitrary units + SEM) and 565 ± 77 respectively, than in controls (403 
± 67) the overall difference remained non-significant (p=0.205, ANOVA). For the 
other activities, no indications were found for the existence of differences between 
control and experimental groups (data not shown).
Histology 
No gross differences were observed in the architecture of the 7 days old anastomoses 
(H&E staining) in either ileum or colon between control rats and animals treated 
with diclofenac or naproxen. In Figure 6 examples of ileal anastomoses from the 
control, diclofenac and naproxen groups are shown.  The architecture of the 
wound area in the abdominal wall was also similar in all groups (not shown). 
COX-1 was abundantly present in mucosa and granulation tissue in controls and 
diclofenac-treated animals, but less so in naproxen-treated animals (Figure 6, 
middle row). COX-2 immunoreactivity was clearly seen in controls but seemed 
hardly present in both drug-treated animals (Figure 6, lower row).
significantly from day 3 to day 7. There was no significant difference between groups 
on either day 3 or day 7 (Figure 5). Also, histological quantification of collagen in 
the true wound area showed large inter-animal variation and a similar range in 
the three groups (data not shown).
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Figure 5  Hydroxyproline content of ileal anastomoses.  Bars represent mean and 
SEM in anastomotic segments from the control, diclofenac and naproxen groups on 
day 3 (white bars) and day 7 (black bars) *, p<0.05 (day 3 versus day 7).
Figure 3  Anastomotic breaking strength. Data represent mean and SEM (in g) 
for ileal (A) and colonic (B) anastomoses in control, diclofenac, naproxen  and the 
diclofenac and naproxen delay groups.
Figure 4  Breaking strength in the abdominal wall.  Data represent mean and SEM 
(in g/mm) in the control, diclofenac, naproxen and the diclofenac and naproxen 
delay  groups.
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postoperative pain in adults. 20;21 In our study we have used doses for both diclofenac 
22 and naproxen 23;24 which exert relevant antinociceptive effects in the rat.
The present data add to incidental reports on interference of NSAIDs, and especially 
those with an enhanced specificity for COX-2, in anastomotic healing. Celecoxib 14 
appears to be similar in its effects on ileal anastomoses to diclofenac, such as 
reported here, while rofecoxib affects colonic anastomoses13 but valdecoxib does 
not. 25 Effects on anastomoses in the small bowel have not been investigated for the 
latter compounds. Clinically, enhanced anastomotic leakage is reported when 
celecoxib is administered after colonic surgery. 26;27 
To our knowledge, there are no data yet on naproxen and anastomotic healing, 
either clinically or experimentally. Negative effects for diclofenac on ileal 
anastomoses have been described in rabbits. 11 Contrary to our experiment, the 
drug was administered intramuscularly. The same route was used in two 
investigations on its effect on colonic healing, although with contradictory results. 
While Inan et al. 16 suggest reduced bursting pressures at 3 and 7 days after 
operation, Klein et al. 15  report an unchanged breaking strength after 3 days. The 
latter is in agreement with the present data although we investigated colonic 
healing in animals which had an anastomosis in the ileum as well. In our opinion, 
with this experimental design, which halves the number of experimental animals 
needed, it is allowed to draw conclusions about both anastomoses separately. 
Previous work in our laboratory with celecoxib 14 and the veterinary COX-2 
inhibitor carprofen 28 has shown that effects in animals with two anastomoses 
could be repeated in animals with one anastomosis only.
Next to these experimental data there is some clinical, although retrospective, 
evidence that diclofenac can affect anastomotic healing and increase the 
anastomotic leakage rate. 29-31 Evidence appears to be accumulating that may be 
taken as a warning to be aware of risks if this class of compounds is used to treat 
acute pain in the immediate postoperative period. The finding that the pronounced 
negative effect of diclofenac can be prevented by postponing its first use with a few 
days may be taken in consideration in choosing an appropriate drug regimen.
The mechanism that causes diclofenac to interfere with the healing anastomosis 
remains to be elucidated. Generally speaking, COX-1 activity does not change 
during the inflammatory process, while there is a dramatic increase in COX-2 
levels leading to increased production of proinflammatory prostaglandins. COX-2 
was thought to be absent in undamaged tissue. This initial concept is now 
challenged and in fact the COX-2 enzyme appears to play a regulatory role in 
maintaining gastrointestinal barrier function and motility. 31-33 
It has been reported 34 that constitutive COX-2 expression varies along the gastro-
intestinal tract of the rat and is highest in the ileum, which may explain why its 
inhibition is most severely felt around the ileal anastomosis.
Discussion
Administration of diclofenac immediately after intestinal surgery strongly affects 
ileal anastomotic healing in the rat as demonstrated by a very high leakage rate 
and substantial mortality. This effect is also observed for naproxen, although to a 
much lesser extent. When drug administration is withheld for three days these 
complications are prevented. Healing of the colonic anastomoses and the abdominal 
wall remains unaffected.
It is very relevant to gain knowledge about the potential drawbacks of the use of 
these two drugs. Both have been proven to provide effective analgesia for acute 
3
Figure 6  Anastomotic histology in the ileum at day 7 after surgery. Each panel 
shows a tissue segment with the  ileal anastomosis in the middle and the mucosal 
layer on top at a magnification of approximately x100 in control  (C), diclofenac 
(D) and naproxen (N) groups. The photomicrographs represent typical examples of 
hematoxylin and eosin-stained sections (first row) and specific staining for COX-1 
(second row) and COX-2 (third row). The arrows indicate substantial deposition of 
immunoreactive material.
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Peri-operative analgesia is ever increasing and expanding and drugs that inhibit 
COX isoenzymes like NSAIDs are invariably part of regimens used for this purpose 
after major surgery. 35;36 Selective COX-2 inhibitors have been developed to prevent 
the side effects induced by classical NSAIDs through inhibition of COX-1 resulting 
in platelet aggregation and gastric mucous production. The COX-1/2 inhibitory 
potency and selectivity of the various NSAIDs available varies widely. Diclofenac is 
far more selective for COX-2 than naproxen. 2;37;38 It could very well be that 
increasing selectivity for COX-2 goes together with higher chances for wound 
disruption. Although the more selective NSAIDs may be preferred for reasons of 
preventing side effects, one should realize this is indeed very valuable for chronic 
users, but that in the short postoperative period it is more important for analgesia 
not to interfere with the healing process. 
Thus, although the role of COX-2 in wound healing is not completely clear and the 
mechanisms responsible remain to be unraveled, our data add to the increasing 
body of evidence which suggests that one should be aware that NSAIDs may 
negatively affect the outcome of the wound healing sequence. Within this context, 
the new finding that a short postoperative delay in their administration prevents 
this effect may be clinically relevant.
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Abstract
Background We examined the potential of the cyclooxygenase (COX) 2 inhibitor 
carprofen to reproducibly induce anastomotic leakage.  
Methods In experiment 1 an anastomosis was constructed in both ileum and 
colon of 20 rats and they were given carprofen (5 mg/kg subcutaneously every 24 
hours) or buprenorphine (0.02 mg/kg subcutaneously every 12 hours). In another 
20 rats an anastomosis was constructed in either ileum or colon and all received 
carprofen (experiment 2). Animals were killed after 3 days.
Results In experiment 1 the ileal dehiscence rate was 60% in the carprofen group 
and 0% in the buprenorphine group (p=0.0108). Colonic anastomoses in both 
groups remained patent. In experiment 2 the anastomotic leakage rate was 80% in 
ileum and 0% in colon.
Conclusion Thus, COX-2 inhibitors can severely interfere with intestinal healing, 
particularly in the ileum. Peri-operative administration of carprofen yields an 
unique model for anastomotic leakage which allows translational research on the 
effectiveness of perisuture line reinforcement.
Introduction
Despite advances in surgical techniques, anastomotic leakage remains a feared 
and dangerous complication after gastrointestinal surgery. Dehiscence, with a 
reported incidence varying between 1 and 30% 1-3 is attended by high morbidity 
while its mortality rate is believed to fall between 
10 and 15%. 1;4
The incidence of anastomotic dehiscence and the severity of its consequences ask 
for ways to protect anastomotic integrity, particularly if intestinal continuity 
needs to be restored in conditions which have been associated with high leakage 
rates. The development of such procedures requires preclinical evaluation and 
thus an animal model for anastomotic dehiscence. So far, the only known way to 
mimic a leaking anastomosis consists of the creation of an iatrogenic defect during 
its construction, mostly by using an insufficient number of sutures. 5-8 However, 
ideally, a complete and patent anastomosis should be constructed which develops 
dehiscence with time. Such a model would be less artificial and clinically more 
relevant and would offer an unique possibility for translational research. In 
particular, it would allow to investigate the efficacy of means to prevent leakage or 
contain or postpone its effects, such as peroperative application of biological 
sealants. To our knowledge, there is no such experimental model available.
Previous work in our laboratory has indicated that inhibitors of cyclooxygenase 
(COX) may interfere with anastomotic repair in the intestine. 9;10 Peri-operative 
celecoxib, an inhibitor with a preference for COX-2, even induces leakage of ileal, 
but not colonic, anastomoses resulting in considerable mortality. 9 This finding 
suggests that controlled application of a suitable drug from this class might result 
in reproducible leakage rates, without excessive mortality, in initially patent small 
bowel anastomoses. 
Carprofen is an analgesic, widely used in veterinary medicine, which is believed to 
possess a certain degree of selectivity for COX-2 11 and is suitable for pain relief during 
surgery in the rat. 12 The present prospective study aims to demonstrate that the 
perioperative use of carprofen affects the integrity of ileal anastomoses and yields 
a much-needed reproducible model for anastomotic leakage in the rat intestine. 
Methods 
Study Design 
Forty male Wistar Rats were used for the study: 20 (experiment 1) were obtained 
from Harlan BV, Horst, The Netherlands and another 20 (experiment 2) form 
Charles River, Sulzfeld, Germany. All were housed 2 per cage and accustomed to 
4
56 57
line with or without an abscess near it. All fibrin-encased, purulent collections 
were considered to represent abscesses. 
The presence of abscesses alone was not considered to be a sign of leakage. 
Adhesions were dissected carefully without manipulation of the anastomosis. 
Segments containing the anastomoses were resected and bursting pressure and 
breaking strength were measured consecutively. To measure bursting pressure, 
the segments were infused (2 ml/min) with 0.9% NaCl containing methylene blue. 
The maximum pressure (mm Hg) recorded immediately before sudden loss of 
pressure was taken as the bursting pressure. The site of rupture (within or outside 
the anastomotic line) was noted. Subsequently, the same segments were placed in 
a tensiometer, and the breaking strength (g) was measured. 13
Biochemical analysis
After weighing, tissue samples were frozen, lyophilized and pulverized. The hydro-
xyproline content, as a measure of the collagen content, was measured by high-
performance liquid chromatography (HPLC) after hydrolysis with 6 N hydrochloric 
acid and coupling to dabsyl-chloride. 
Preparation of tissue extracts for gelatin zymography, using a buffer containing 
1% (v/v) Triton X-100, has been described elsewhere. 14 The protein concentration of 
the extracts was measured using the bicinchoninic acid reagent. All tissue samples 
were stored at −80°C until zymography. The technique of preparation and electro-
phoresis of the gels and quantification of the various enzyme activities, which 
were expressed as arbitrary units on the basis of the lysed area, using a Sharp 
Jx-330 scanner and Imagemaster 1D software (Amersham Pharmacia, Uppsala, 
Sweden) has been described previously. 14 In-between comparison of values 
obtained on different gels was performed using collagenase type 1 (from 
clostridium histolyticum; Sigma, St. Louis, MO, USA) as an internal standard. The 
presence of true matrix metalloproteinase (MMP) activity was confirmed by adding 
10 mM EDTA or 1,10 phenanthroline to the buffers used after electrophoresis.
Statistics
Group size was estimated on the basis of the expectation (based on prior 
experiments in our laboratory) of a 0% ileal leakage rate in the control group and 
at least 60% leakage in the carprofen group. Using an α of 0.05 and a power of 0.8 
an one-tailed Fisher’s exact test puts the group size at 10 (G*Power). Further 
comparisons between control and experimental groups was performed using a 
two-tailed unpaired t-test. Results were considered statistically significant at 
p<0.05.
laboratory conditions for five days before the start of the experiment. Body weights 
ranged between 260 and 300 g at operation. For experiment 1, the animals were 
divided randomly over two equal groups, which underwent intestinal resection 
and anastomotic construction in both colon and ileum. Starting before operation, 
group 1 received buprenorphine as an analgesic and group 2 carprofen. For 
experiment 2, the animals were again randomly divided over two equal groups, 
which underwent resection and anastomosis of either ileum (group 3) or colon 
(group 4). Both groups received analgesia by carprofen (Table 1). All rats were 
observed closely and weighed daily until termination at day 3 after operation. 
They had free access to water and standard rodent chow (Hope Farms, Woerden, 
The Netherlands). The Animal Ethics Review Committee of the Radboud University 
Nijmegen approved the study.
Procedure
Procedures were performed under semi sterile conditions using a Zeiss operation 
microscope (Carl Zeiss AG, Oberkochen, Germany). Animals were anesthetized by 
use of a mixture of isoflurane, oxygen and nitrogen, while breathing spontaneously 
through a mask. A midline laparotomy was performed and a 1-cm segment was 
resected from the descending colon 3 cm proximal to the peritoneal reflection. 
Colonic continuity was restored by constructing an end-to-end anastomosis with 8 
single-layer, inverting, interrupted sutures (Ethilon 8-0; Ethicon, Norderstedt, 
Germany).  A similar procedure was performed in the distal ileum 15 cm proximal 
to the cecum.
During operations, body temperature was kept at 38°C using a heating pad and a 
lamp. Intestines were covered with gauze pads soaked with 0.9% NaCl to minimize 
desiccation. To prevent dehydration, 10 ml of 0.9% NaCl was administered 
subcutaneously during the operation. Group 1 was administered buprenorphine 
(Temgesic, Schering Plough, Houten, the Netherlands), 0.02 mg/kg, every 12 hours 
(5 times in total) for 48 hours. The other three groups were administered carprofen 
(Rimadyl, Pfizer Animal Health, Cappele aan de IJssel, the Netherlands), 5 mg/kg 
every 24 hours (three times in total) for 48 hours. Both analgesics where 
administered subcutaneously and the first dose was given immediately prior to 
surgery.
Necropsy and analysis of wound strength
Rats were killed by CO/CO
2
 asphyxiation on postoperative day 3 and the abdomen 
was inspected. The observers were blinded to the treatment groups. In particular, 
attention was paid to signs of anastomotic leakage such as macroscopic dehiscence 
of the anastomosis, the presence of faecal peritonitis, a puncture in the anastomotic 
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and 23 ± 7 g, respectively. In both groups 2 and 3 the bursting pressure in animals 
which showed macroscopic signs of anastomotic leakage at necropsy was considerably 
lower than that in the rats without these signs (Figure 3). The colonic anastomotic 
strength in experiment 1 was similar in control (group 1) and  carprofen (group 2) 
animals.
Results
General observations
Postoperative weight loss at day 3 was around 10% and similar in all groups. Two 
rats died prematurely after 2 days, one in group 2 and one in group 3. In both, a 
complete dehiscence of the ileal anastomosis was seen with faecal peritonitis 
(Figure 1a), while in the animals in group 2 the colonic anastomosis was intact. At 
termination of experiment 1, another five rats in the carprofen group (group 2) 
showed signs of ileal anastomotic leakage (Figure 1b). The colonic anastomoses all 
remained intact. In the buprenorphine group (group 1) there were no signs of 
anastomotic leakage in either ileum or colon. Thus, the ileal leakage rate was 
significantly (p=0.0108) elevated by carprofen (Table 1). In the second, independent, 
experiment in animals with one anastomosis the use of carprofen led to ileal 
leakage in 80% of the animals while all colonic anastomoses remained intact 
(p=0.0007 vs ileum).
Wound Strength
During bursting pressure analysis all anastomoses ruptured within the suture 
line. The mean bursting pressure of the ileal anastomoses was significantly (p = 
0.0005) lower in the carprofen treated animals in experiment 1 (group 2; 25 ± 8 
mm Hg, mean + SE) than in the control group (group 1; 67 ± 6 mm Hg), while the 
difference in breaking strength (39 ± 7 vs 50 ± 9 g) did not reach significance 
(Figure 2). This low wound strength was also found in the ileal anastomoses from 
group 3, where bursting pressure and breaking strength averaged 31 ± 10 mm Hg 
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Figure 1  Macroscopic aspects of anastomotic leakage. a: complete dehiscence with 
faecal peritonitis; b: a defect in the suture line.
Figure 2  Anastomotic strength in experiment 1. Bars represent mean + SEM for 
bursting pressure (A) and breaking strength (B) in control (n=10, grey bars) and 
carprofen (n=9, open bars) group. * p = 0.0005 versus control group.
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Table 1  Experimental design and anastomotic leakage rate
experiment 1 experiment 2
Group 1 (n=10) 2 (n=10) 3 (n=10) 4 (n=10)
Analgesic Buprenorphine Carprofen Carprofen Carprofen 
Anastomosis Ileum Colon Ileum Colon Ileum Colon 
Leakage rate 
(%) 
0 0 60 0 80 0
In experiment 1 an anstomosis was constructed in ileum and colon. 
In experiment 2 an anastomosis was constructed either in ileum or colon.
a b
60 61
Discussion
Healing of the ileal anastomosis in the early postoperative phase is impaired by 
the administration of carprofen to such extent that it results in reduced wound 
strength and a dehiscence rate of 60-80%. The fact that this COX inhibitor can elict 
such profound effects in the ileum, though not in the colon, should be taken as a 
further warning that anti-inflammatory analgesics may interfere with tissue 
repair. However, at the same time it offers an opportunity to establish a long-wanted 
model for anastomotic leakage, without iatrogenic disruption of the anastomotic 
integrity.
Leakage of intestinal anastomoses remains a relatively frequent disaster which 
can result in generalized peritonitis and a need for reoperation. The patient has to 
deal with this challenge while still recovering from the initial operation. Any 
methods which would either prevent peritonitis to occur, or postpone its clinical 
effects, would constitute enormous progress. For this purpose, the potential 
benefits of peroperative suture or staple line reinforcement 15, for example by 
means of fibrin sealant 16;17, need investigation. 
Finally, mean anastomotic strength in animals with only a colonic anastomosis 
which had received carprofen (group 4) was high: 64 ± 9 mm Hg and 155 ± 10 g for 
bursting pressure and breaking strength, respectively. 
Collagen and proteolytic activity
Analysis of collagen and proteolytic activity was measured in experiment 1 where 
both an ileal and a colonic anastomosis were constructed within the same rat: 
group 1 (control) and group 2 (carprofen).The mean hydroxyproline content was 
similar in the ileal anastomosis of group 1 (161 ± 16 μg/5 mm) and group 2 (140 ± 
28 μg/5 mm) group. The respective hydroxyproline concentrations were 10.5 ± 0.5 
and 9.7 ± 0.8 μg/mg dry weight. Likewise, no differences between groups were found 
in colon anastomoses for these parameters.
Gelatin zymography of anastomotic extracts demonstrated the presence of multiple 
gelatin-degrading activities, representing various forms of matrix metalloproteinase 
MMP-2 and MMP-9. Administration of carprofen did not influence the activity of 
any of the gelatinases present in either the ileal or colonic anastomoses. Figure 4 
shows both the specific and total activity in ileal anastomoses of proMMP-2 and 
active MMP-2 as an example.
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Figure 3  Anastomotic bursting pressure in the ileum. Bars represent mean + SEM 
for animals which showed macroscopic signs of dehiscence at obduction (open bars) 
and animals without these signs (grey bars). Results are given for both experiment 
1 (group 2, n=4 for grey bar and n=5 for open bar) and experiment 2 (group 3, n=2 
for grey bar and n=7 for open bar) * P < 0.05.
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Figure 4  MMP-2 activity in ileal anastomoses from experiment 1. Bars represent 
mean + SEM for specific (A) and total (B) activity of both pro- and active MMP-2 in 
control (n=10, grey bars) and carprofen (n=9, open bars) groups.
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a regulatory role in maintaining gastrointestinal barrier function and motility 
and is needed to maintain small bowel integrity. 23;24 The fact that constitutive 
COX-2 expression appears to vary along the gastrointestinal tract of the rat and is 
highest in the ileum 25 may explain why its inhibition is most severely felt around 
the newly-made ileal anastomosis.
Peri-operative analgesia is ever increasing and expanding and drugs that inhibit 
COX isoenzymes are invariably part of regimens used for this purpose after major 
surgery. 26;27 Although the mechanisms responsible remain to be fully understood, 
there appears to be an increasing body of evidence which suggests that one should 
be aware that analgesic drugs may affect the outcome of the wound healing 
sequence.
In conclusion it should be emphasized that we do not propose carprofen-induced 
ileal dehiscence to be a model to study the aetiology of leakage of intestinal 
anastomoses. Rather, it provides a means to perform much needed translational 
research on the effectiveness of peroperative suture line reinforcement.
In order to assess such procedures a sound preclinical model is required. So far, 
basic research on intestinal healing is mostly performed in models with intact 
anastomoses. If constructed properly, intestinal anastomoses in rodents do not 
leak. Therefore, anastomotic strength is taken as a parameter which reflects its 
propensity to leak. However, a model which displays actual dehiscence of 
essentially patent anastomoses with time would be unique and clinically very 
relevant. The present data demonstrate that the administration of carprofen 
before and after anastomotic construction in the ileum results in the desired 
sequence of events in a high percentage of the animals. The fact that the expected 
leakage rate is somewhat less than 100% might be taken as a limitation of the 
model. Still, in our opinion the leakage rate is such that the effectiveness of 
procedures to lower the dehiscence rate can be established with reasonable 
numbers of animals. This will allow preclinical examination of, for instance, the 
efficacy of various sealing procedures for preventing anastomotic dehiscence. 
The mechanism underlying the effects described are as yet poorly understood. 
Carprofen is an analgesic widely used in veterinary medicine. 11 It is used here in 
the dose recommended for per- and post-operative pain relief. Carprofen inhibits 
COX and exhibits a preference for COX-2. 18;19 Preclinical 9;20 and clinical 21 data 
have been reported suggesting that COX-2 inhibitors can negatively affect 
anastomotic repair. Early wound strength depends on the capacity of the existing 
subcellular matrix to retain sutures. Loosening of the matrix by degradation of its 
structural components, mediated by MMP-activity, could precede anastomotic 
leakage. In our experiments, carprofen reduces the anastomotic breaking strength 
to a lesser extent than the bursting pressure. This observation may indicate matrix 
degradation to be very localized since a minute gap in the bowel wall will only 
lower the bursting pressure. 13 If so, this would also explain why hydroxyproline 
levels, as a measure for collagen in the anastomotic segments, remain unchanged. 
Also unchanged are both the gelatinase activities which are abundantly present in 
the wound area during the first postoperative days. 14 Since activities were only 
measured after 3 days, it cannot be ruled out that MMP-2 or -9, or possibly other 
members from the MMP family, are elevated at an earlier stage, although it is 
believed that COX-2 inhibitors generally suppress MMP activity. 22 The fact that 
anastomotic dehiscence was observed in the 2 rats that died prematurely suggests 
that the process responsible may originate in the very first postoperative period.
The mechanism responsible for the negative effect of carprofen on the healing 
anastomosis remains unknown as yet. At first, COX-2 levels were thought to be 
virtually absent in undamaged tissue, while the enzyme is strongly expressed 
during the inflammatory process.
Indeed, anastomotic construction leads to upregulation of COX-2 in the wound 
area in both small and large bowel. 9 However, it now seems likely that COX-2 plays 
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Abstract
Background There is increasing evidence that perioperative use of non-steroidal 
anti-inflammatory drugs (NSAIDs) may compromise the integrity of intestinal 
anastomoses. This study aims to characterize the negative effects of carprofen on 
early anastomotic healing in the rat ileum.
Methods In 159 male Wistar rats an anastomosis was constructed in the ileum. In 
experiment 1 eighty-four rats were divided over control and experimental groups, 
which received daily buprenorphine or carprofen, respectively, as an analgesic 
and were killed on day 1, 2 or 3 after surgery. In experiment 2 three groups of 15 
rats received carprofen either immediately after surgery or with a delay of 1 or 2 
days. Animals were killed after 3 days of carprofen administration. In experiment 
3 three groups of 10 rats received different doses (full, half or quarter) of carprofen 
from surgery. 
Results In significant contrast to buprenorphine, which never did so, carprofen 
induced frequent signs of anastomotic leakage, which were already present at day 
1. If first administration was delayed for 48 hours, the leakage rate was significantly 
reduced (from 80 to 20%; p=0.0028). Throughout the study, the anastomotic 
bursting pressure was lowest in animals who displayed signs of anastomotic 
leakage. Loss of anastomotic integrity did not coincide with reduced levels of 
hydroxyproline or increased activity of matrix metalloproteinases.
Conclusion Carprofen interferes with wound healing in the rat ileum at a very 
early stage. Although the mechanisms responsible remain to be fully elucidated, 
one should be aware of the potential of NSAIDs to interfere with the early phase of 
wound repair.
Introduction 
The use of analgetics in veterinary medicine is still relatively low, but adequate 
management of animal pain is becoming increasingly important in companion, 
farm and laboratory animals. 1;2 
Human pain control strategies using opiods or non-steroidal anti-inflammatory 
drugs (NSAIDs) can be applied to animals, because most animals possess neuronal 
mechanisms for pain perception which are similar to humans. 3 NSAIDs inhibit 
cyclo-oxygenase (COX), enzymes which catalyze the first two steps in prostanoid 
biosynthesis. These enzymes occur as isoforms COX-1 and COX-2. COX-1 is expressed 
constitutively in housekeeping functions, whereas COX-2 is expressed mainly in 
response to external stimuli. One widely used NSAID in veterinary medicine is 
carprofen, which is believed to possess a certain preference for COX-2 4 and is 
suitable for pain relief. It is mostly used in dogs and cats but also in cattle and in 
laboratory animals. If carprofen is used as an analgetic during and after surgery of 
the intestine in rats the healing of ileal, but not of colonic, anastomoses is seriously 
compromised. 5 A similar effect was found previously for celecoxib, another inhibitor 
with a certain degree of specificity for COX-2. 6 Such a negative effect could have 
implications for the use of carprofen in veterinary practice and laboratory animals, 
particularly if used in the peri-operative period. 
The present experiments were conducted to expand our earlier preliminary findings 5 
and further investigate the effects of carprofen on the healing of anastomoses in 
the small intestine of the rat.
Methods 
Study design
Hundred and fiftynine male Wistar rats weighing 250-290 g (Charles River, Sulzfeld, 
Germany) were housed 2 per cage and accustomed to laboratory conditions for five 
days before the start of the experiment. All rats underwent intestinal resection 
and an anastomosis was constructed in the ileum. Animals were observed closely 
and weighed daily and had free access to water and standard rodent chow (Hope 
Farms, Woerden, The Netherlands) throughout the entire experimental period. 
When observing the rats attention was paid to activity, colour and aspect of nose, 
presence of diarrhoea, aspect of fur and tenderness of the abdomen. If the rats 
scored as abnormal on all of these points they were taken out of the experiment, 
always after consultation of one of the experienced biotechnicians.
In experiment 1, 84 rats were randomly divided into two cohorts of 42 rats, each 
consisting of three groups of 14 animals to be killed on day 1, 2 or 3 after surgery. 
5
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Necropsy and analysis of wound strength
The rats were killed by CO/CO
2
 asphyxiation. The abdomen was inspected and 
particular attention was paid to signs of anastomotic leakage defined such as 
macroscopic dehiscence of the anastomosis, the presence of faecal peritonitis or a 
puncture in the anastomotic line with or without an abscess near it. If necessary 
(in order to resect the segment) adhesions were dissected carefully without 
manipulation of the anastomosis proper. Segments containing the anastomoses 
were resected en bloc. 
To measure bursting pressure, the segments were infused (2 ml/min) with 0.9% 
NaCl containing methylene blue. The maximum pressure (mm Hg) recorded 
immediately before sudden loss of pressure was taken as the bursting pressure. 
The site of rupture (within or outside the anastomotic line) was noted. Subsequently, 
the same segments were placed in a tensiometer, and the breaking strength (g) was 
measured. 7 The anastomotic segments were carefully cleaned from any adhering 
tissue and 5 mm samples, containing the suture line in the middle, were frozen in 
liquid nitrogen and stored at -80 °C until further processing.
Biochemical analysis
After weighing, tissue samples were frozen, lyophilized and pulverized. The 
hydroxyproline content, as a measure of the collagen content, was measured in 
experiment 1 by high-performance liquid chromatography (HPLC) after hydrolysis 
with 6 N hydrochloric acid and coupling to dabsyl-chloride.
In experiment 1gelatin zymography was performed. Tissue extracts were prepared 
using a buffer containing 1% (v/v) Triton X-100. The protein concentration of the 
extracts was measured using the bicinchoninic acid reagent. All tissue samples 
were stored at −80°C until zymography. The techniques for preparation and elec-
trophoresis of the gels and quantification of the various enzyme activities have 
been described previously. 8 
Histology
Intestinal samples of approximately 1 cm containing the entire anastomosis in the 
middle were carefully collected en bloc, opened at the mesenteric side, washed 
gently in 0.9% NaCl and spread out in a cassette for paraffin-embedding. From 
paraffin-embedded tissues, 4 μm sections were prepared and stained with 
hematoxylin and eosin (H&E).  The presence of COX-1 and COX-2 protein in healing 
anastomoses was visualized by immunohistochemistry.  From the paraffin-embed-
ded tissues 4 μm sections were prepared and stained as described previously. 6 
COX-1 and COX-2 proteins were visualized using a rabbit polyclonal antiserum 
against human COX-1 and COX-2 (Cayman Chemical, An Arbor, MI, USA). 
The controls were administered buprenorphine and the experimental animals 
received carprofen as an analgetic (Table 1). Ten rats from each group were analysed 
for wound strength and the remaining animals were used for histology.
In experiment 2, 45 rats were randomly divided over three equal groups. All 
received carprofen for three days, starting immediately after surgery or 1 or 2 days 
afterwards. Animals in the three groups were killed on day 3, 4 or 5 after surgery, 
respectively (Table 2). Twelve rats from each group were analysed for wound 
strength and the remaining animals were used for histology.
In experiment 3, 30 rats were divided into three equal groups which each received 
a different daily (full, half or quarter, see below) dose of carprofen from the day of 
surgery. All animals were killed at day 3 (Table 3) and analysed for wound strength. 
The Animal Ethics Review Committee of the Radboud University Nijmegen 
approved the study (RU-DEC 2011-015 and 2011-127).
Surgery and analgesics
Procedures were performed under semi sterile conditions using a Zeiss operation 
microscope (Carl Zeiss AG, Oberkochen, Germany). Animals were anesthetized by 
use of a mixture of isoflurane, oxygen and nitrogen, while breathing spontaneously 
through a mask. 
A midline laparotomy was performed and in each rat a 0.5-cm segment was resected 
from the distal ileum, 15 cm proximal to the coecum. Ileal continuity was restored 
by constructing an end-to-end anastomosis with 8 single-layer, inverting, 
interrupted sutures (Ethilon 8-0; Ethicon, Norderstedt, Germany).  The abdominal 
wall was closed with a running suture (Vicryl 3-0; Ethicon, Norderstedt, Germany). 
The skin was closed with staples. During operations, body temperature was kept at 
38°C using a heating pad and a lamp. Intestines were covered with gauze pads 
soaked with 0.9% NaCl to minimize desiccation. To prevent dehydration, 10 ml of 
0.9% NaCl was administered subcutaneously after the operation. 
All rats in experiment 2 and 3 and the rats in the control group of experiment 1 
were administered buprenorphine (Temgesic, Schering Plough, Houten, the 
Netherlands), 0.02 mg/kg subcutaneously every 12 h for 48 h the first dose was 
administered just prior to surgery. This constitutes the analgesic regimen routinely 
given in our intestinal anastomosis model. 
In experiment 1, rats in the experimental group received only carprofen (Rimadyl, 
Pfizer Animal Health, Capelle aan de IJssel, the Netherlands), 5 mg/kg subcutaneously 
daily immediately before surgery and on days 1 and 2. In experiment 2 animals 
received 3 daily doses of carprofen (5 mg/kg) starting on the day of surgery or 1 or 
2 days afterwards. The rats in experiment 3 received carprofen in different doses 
(5, 2.5 and 1.25 mg/kg, respectively) on the day of surgery and the next 2 days.
5
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Statistics 
Comparison between  more than two groups was  performed using a One-way Analysis 
of Variance (ANOVA). Comparisons between two groups or, within one group, 
between values at two different days were performed with a two-tailed unpaired 
t-test.  Results were considered statistically significant at p<0.05.
Results 
Presence of COX during normal healing
Both COX-1 and COX-2 are expressed during normal healing, if buprenorphine is 
used for peroperative pain relief. Figure 1 shows COX-1 to be present in undamaged 
intestine and also at day 1, 2 and 3 after surgery (Figure 1 panels a-d). COX-2 is 
absent in undamaged intestine but appears at day 1 and, more strongly, at days 2 
and 3 (Figure 1 panels e to h).
Experiment 1: carprofen versus buprenorphine
All animals lost weight after operation. In the buprenorphine group the mean 
(+ SEM) relative weight (vs weight at operation) was 91 ± 1 % at day 3. The corresponding 
value in the carprofen group was 
94 ± 2 % (p=0.0356). One rat from the buprenorphine group died immediately after 
surgery of no discernible reason. In the carprofen group another rat died prematurely 
from anastomotic leakage. No signs of anastomotic leakage were observed in the 
buprenorphine groups. These signs were found increasingly with time, and significantly 
(p<0.05) more frequently at all days, in the carprofen groups (Table 1). 
The anastomotic bursting pressure is depicted in Figure 2A. The biggest difference 
between groups was observed at day 3 where values in the buprenorphine group 
averaged 56 ± 6 (SEM) mm Hg and in the carprofen group 34 ± 10 mm Hg (p=0.0915). 
Clearly, in the carprofen groups the bursting pressure was lowest in animals who 
displayed signs of anastomotic leakage. At day 3, the average anastomotic breaking 
strength (Figure 2B) was also lower (p=0.0729) in the carprofen group than in the 
buprenorphine group, at 26 ± 7 vs  44 ± 6 g, respectively. 
Gelatin zymography revealed the presence of both pro- and active metalloprotein-
ase MMP-2 and -9 in anastomotic extracts. At days 1 and 2 no differences were 
found for any of these activities between buprenorphine and carprofen groups 
(data not shown). At day 3, total activities (in arbitrary units/sample) for both 
pro-MMP-2 and active MMP-2 were higher in the buprenorphine groups: 571 ± 62 
vs 313 ± 35 (p=0.0038) and 223 ± 21 vs 133 ± 9 (p=0.0024) respectively. The anastomotic 
hydroxyproline content did not significantly differ between groups at any of the 
days (Figure 3).
5Figure 1  Presence of COX-1 and COX-2 during normal healing. Anastomotic segments 
from the buprenorphine group of experiment 1 were immunostained for COX-1 
(panels on the left) and COX-2 (panels on the right). Panels represent uninjured 
intestine (a and e) and tissue segment with the anastomosis in the middle and the 
mucosal layer on top (at a magnification of approximately x100) at day 1 (b and f), 2 
(c and g) and 3 (d and h) after surgery.
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Experiment 2: delayed administration of carprofen
Weight loss was similar to that observed in experiment 1, with the relative weight 
at day 3 averaging 93, 91 and 93 % in the groups receiving carprofen from day 0, 1 
or 2, respectively.  Two rats which received carprofen from day 1 after surgery died 
prematurely on day 3 due to anastomic leakage. As before, signs of anastomotic 
leakage were seen frequently if carprofen was given from day 0 (Table 2). Delaying 
the first gift reduced leakage, significantly so if carprofen was only given from day 
2 onwards, although in that group signs were still observed in 20 % of the animals 
after termination at day 5. Anastomotic strength did increased with time. Despite 
the fact that the animals also received a three day course of carprofen both 
anastomotic bursting pressure and breaking strength at day 5 were considerably 
and significantly (p<0.001) higher than at day 3 (Figure 4). Again, the bursting 
pressure was lowest in animals who displayed signs of anastomotic leakage.
Experiment 3: different dosage of carprofen 
The weight loss was similar to that in the preceding experiments, with a mean 
relative weight (vs weight at operation) at day 3 of 94, 96 and 94 % in the groups 
receiving full, half or quarter doses of carprofen, respectively. One rat died 
prematurely of anastomotic dehiscence in the group which received the full dose 
of carprofen and another one, of unknown reasons, in the group that received a 
quarter dose. 
5
Table 1  Characteristics of experiment 1
Buprenorphine Carprofen
Group name Bd1 Bd2 Bd3 Cd1 Cd2 Cd3
Number operated  
at day 0
14 14 14 14 14 14
Day of termination 1 2 3 1 2 3
Premature death 
(day)
0 1 (0) 0 0 0 1 (2)
Anastomotic leakage 0 0 0 6* 8* 11*
p=0.02 p= 0.002 p=<0.0001
After termination 10 animals from each group were analysed for wound strength and the remaining 
animals for histology. At obduction, special attention was paid to signs of anastomotic leakage. P-values 
denote significant differences between each carprofen group and the corresponding buprenorphine 
group (Fisher’s two-sided test).
Figure 2  Anastomotic strength in experiment 1. Animals received either buprenorphine 
or carprofen from the day of operation and were terminated at day 1, 2 or 3 after 
operation. Panel A gives the individual bursting pressures (and means as horizontal 
bars) for all animals:  denotes an absence of signs of anastomotic leakage and 
 the presence of such signs. The bursting site was always in the anastomotic line. 
In panel B bars represent mean (+ SEM) for breaking strength.
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The average bursting pressure rose slightly with decreasing dosage of carprofen 
but did not differ significantly between groups (Figure 3). Animals without signs 
of anastomotic leakage showed the highest anastomotic bursting pressure. Breaking 
strength was similar in all groups.
Signs of anastomotic leakage were abundant in all groups (Table 3). Although the 
incidence decreased with dose, this effect remained non-significant with the current 
cohort size.
5
Figure 3  Anastomotic hydroxyproline content in experiment 1. Bars represent 
mean and SEM (in μg hydroxyproline/5mm tissue) in anastomotic segments from both 
the buprenorphine and the carprofen groups at the various days after operation. 
Figure 4  Anastomotic strength in experiment 2. Animals received carprofen 
beginning at the day of operation or the first or second day thereafter and were 
terminated 3 days later. Panel A gives the individual bursting pressures (and means 
as horizontal bars) for all animals:  denotes an absence of signs of anastomotic 
leakage and  the presence of such signs, while  indicates that the bursting site was 
outside the anastomotic line. In panel B bars represent mean (+ SEM) for breaking 
strength.
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Table 2  Characteristics of experiment 2
Immediate 
administration of 
carprofen
Administration  
of carprofen after  
24 hours
Administration  
of carprofen after  
48 hours
Group name d3 d4 d5
Number operated  
at day 0
15 15 15
Day of termination 3 4 5
Premature death 
(day)
0 2 (3,3) 0
Anastomotic leakage 12 7 3*
After termination 12 animals in each group were analysed for wound strength and the remaining 
animals for histology. Signs of anastomotic leakage were noted at obduction. P-value denotes a 
significant difference with the group administered carprofen from day 0 (Fisher’s two-sided test). 
78 79
Discussion
Carprofen interferes with early repair of ileal anastomoses in the rat. Signs of 
anastomotic leakage comprise the main outcome parameter in this study. If 
carprofen is used from the day of operation, these signs are already abundantly 
present 24 hours later. Delaying the first gift of carprofen for 48 hours significantly 
reduces signs of leakage, without completely preventing them. Reducing the dose 
fourfold lowers the incidence of this complication, but not significantly so.
NSAIDs are commonly used in small animals and equine practice for peri-operative 
pain relief because of their analgetic and anti-inflammatory features. NSAIDs 
inhibit the family of COX enzymes. COX-2 is expressed mainly in response to 
external stimuli and is postulated to be involved in essentially pathological 
conditions such as inflammation, pain and fever. 9 Selective inhibitors of COX-2 
supposedly allow specific targeting of inflammatory disease processes, without 
disruption of normal homeostatic mechanisms that accounts for many side-effects 
of non-selective NSAID therapy. Both COX-1 and -2 are believed to be involved in 
wound healing 10;11 and Figure 1 demonstrates their presence in the healing 
anastomosis. There is a growing understanding that NSAIDs, and especially those 
with a certain preference for COX-2, may increase the risk of anastomotic leakage. 
12;13 Carprofen is such a drug that is used in domestic animals 14, but is also effective 
as an analgesic in laboratory animals undergoing laparotomy. 15 Recent evidence 
shows that its long-term use can inhibit bone healing in dogs 16, but nothing is 
known about its potential effects on soft tissue healing. Recent incidental reports 
suggest that carprofen administration to dogs alters functions of platelets, which are 
relevant to the repair sequence. 17 Also, carprofen has been shown to compromise 
the integrity and barrier function of the gastrointestinal mucosa in dogs. 18 The 
present data, which expand on a previous short communication  5 unequivocally 
demonstrate that carprofen can interfere significantly with anastomotic integrity 
in the rat small bowel. 
While signs of leakage in the carprofen group greatly surpass those in the bupre -
norphine group (Table 1), the average anastomotic strength is not dramatically 
reduced (Figure 1). It seems likely that in the majority of animals the leakage can 
be contained, e.g. by the formation of fibrinous adhesions. This way, some degree 
of strength is restored to the anastomotic segment. On the whole though, 
5
Panel A gives the individual bursting pressures (and means as horizontal bars) for all 
animals:  denotes an absence of signs of anastomotic leakage and  the presence 
of such signs. The bursting site was always in the anastomotic line. In panel B bars 
represent mean (+ SEM) for breaking strength.
Table 3  Characteristics of experiment 3
Full dose Half dose Quarter dose
Number operated  
at day 0
10 10 10
Day of termination 3 3 3
Premature death 
(day)
1 (2) 0 1 (3)
Anastomotic leakage 9 8 6
All animals, except those who died prematurely, were terminated at day 3 and analysed for wound 
strength. Signs of anastomotic leakage at obduction were noted.  
Figure 5  Anastomotic strength in experiment 3. Animals received different doses of 
carprofen from the day of operation and were terminated at day 3 after operation. 
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from our own laboratory suggest that diclofenac, another inhibitor with specificity 
for COX-2, shows effects similar to carprofen, while naproxen, with a suspected 
lesser specificity for COX-2, leaves ileal anastomoses intact (unpublished results), 
Older data indicate increased complications in rats with anastomoses in both 
ileum and colon after preoperative administration of either ibuprofen or 
indomethacin. 23 It thus remains to be determined if preference for COX-2 is 
essential for a drug to exert the negative effects observed.
It is necessary to gain knowledge about the potential drawbacks of NSAIDs like 
carprofen, as they are rapidly becoming cornerstones in peri-operative pain relief 
and are able to minimize post-operative opioid requirement in veterinary practice 
and in experimental studies. 2;24 The findings reported here may also be relevant to 
the human situation where NSAIDs are frequently used after gastro-intestinal 
surgery and are even incorporated in protocols for fast track surgery, despite 
emerging evidence that they may affect repair.12;13 
Thus, we conclude that carprofen interferes with wound healing in the rat ileum 
at a very early stage. If it does not kill the animal, at least it renders it more 
vulnerable to second hits after initial surgery. Although the mechanisms 
responsible remain to be fully understood, there appears to be an increasing body 
of evidence which suggests that one should be aware that NSAIDs may affect the 
outcome of the wound healing sequence.
throughout the three experiments anastomoses which display signs of leakage at 
necropsy display lower bursting pressures than those that are free of such signs. 
These findings raise the question what the fate would have been of the animals 
which survive until day 3 or later, but which show signs of leakage. Most likely, 
those with zero bursting pressure, thus in fact with a gap in the suture line at that 
time, will eventually die from secondary peritonitis. However, the possibility 
cannot be excluded that in some cases a fibrinous adhesion barrier will prevent 
full feacal leakage into the abdominal cavity. The resulting subclinical leakage 
could eventually allow complete healing of the intestinal wall. just as the majority 
of animals with anastomotic strength compatible with normal repair at day 3 may 
be expected to survive and show increasing strength in the proliferative phase of 
healing (as observed in the animals in experiment 2).
From the data presented it is clear that, whatever mechanism is responsible for 
leakage to occur, the origin of the phenomenon must lie within the first days after 
operation. It is not confined to the first 24, or even 48, hours since in the group 
where carprofen was first given at day 2, 20% of the animals still showed proof of 
leakage 3 days later (Table 2). 
Thus, carprofen somehow affects the inflammatory phase of healing, where 
anastomotic integrity is determined by the capacity of the existing submucosal 
matrix to retain sutures. Induction of massive matrix degradation seems unlikely 
since hydroxyproline (collagen) levels in the anastomotic segments remain 
unaffected. Also, total activities of MMP-2 and MMP-9 remain unchanged during 
the first 2 days. These results do not exclude the possibility of limited and  local 
matrix degradation, e.g. around the sutures, by one of the other enzymes from the 
MMP family. Still, it is believed that COX-2 inhibitors generally suppress MMP 
activity. 19
It has been suggested that COX-2 plays a regulatory role in maintaining gastroin-
testinal barrier function and motility and is needed to maintain small bowel 
integrity. 20;21 Interestingly, the effect described here does not occur in colonic 
anastomoses 5 while the highest level of COX-2 expression in normal uninjured 
rats is located on the ileal side of the ileocaecal junction. 22 The question then 
arises if the carprofen effect is mediated specifically through COX-2 and if it is 
species specific. It has been suggested that determining the exact specificity of any 
inhibitor for either of the COX enzymes is frought with practical difficulties and 
may depend on the test and the laboratory that uses it. 4 Still, carprofen seems to 
possess a certain degree of specificity for COX-2, although it may vary between 
species. Thus, as yet the question remains if these findings are limited to laboratory 
animals or that they can also occur in dogs and cats. Using a commercially 
available formulation and the manufacturer’s recommended dose it seems likely 
that carprofen also produces significant inhibition of COX-1. 4 Very recent data 
5
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Abstract
Background Anastomotic dehiscence remains the most feared complication after 
gastrointestinal surgery. Protecting the anastomotic integrity remains an important 
goal for ongoing research. It seems logical to investigate if a seal, such as fibrin 
glue, around the anastomosis can prevent leakage. The paucity of any clinical 
studies investigating such a procedure is surprising and possibly caused by incidental 
preclinical data which suggest a negative effect on anastomotic strength. We 
performed a comprehensive study into the effect of fibrin glue on the early phase 
of anastomotic healing.
Methods In 108 young adult male Wistar rats resection and anastomosis of ileum 
and colon was performed. Fibrin glue applied around anastomoses in the experimental 
group.
Wound strength, both bursting pressure and breaking strength were measured at 
day 1, 3 and 5 after operation. Hydroxyproline content and histology were also 
measured, the latter also after 7 days.
Results Anastomotic breaking strength was always similar in both control and 
fibrin glue groups. Anastomotic bursting pressures remained low at day 1 and day 3, 
without any differences between groups. At day 5 the bursting pressure in the 
fibrin glue group remained below that in the controls, although only significantly 
(p=0.0138) so in the ileum. Still, in both groups the bursting pressure increased 
sharply between days 3 and 5, by a factor 3.17 (p<0.001) and 2.85 (p<0.001) in 
controls and the experimental group, respectively. At day 5, but not at day 7, the 
wounds in the fibrin glue group appeared to contain less collagen. Other aspects of 
microscopic wound architecture appeared to be the same.
Conclusion During normal healing, fibrin glue does not affect early anastomotic 
strength in a clinically relevant way. Caution with extrapolation to clinical situation 
is warranted. 
Introduction
Anastomotic dehiscence is the most feared and potentially devastating complication 
after gastrointestinal surgery. A leaking anastomosis is associated with increased 
morbidity and considerable mortality. 1;2 Protecting the anastomotic integrity and 
finding ways to minimize, postpone or prevent the consequences of leakage therefore 
remain important goals of ongoing research. In theory it seems logical to apply 
some kind of seal around the anastomosis to prevent leakage. Very recently, it has 
been emphasized again that the potential benefits of such suture or staple line 
reinforcement need investigation. 3 In this respect a possible role for tissue glues 
should not be overlooked.
Tissue adhesives or glues, and in particular fibrin glue, are already used in different 
fields of surgery to promote tissue union, sealing, hemostasis and wound healing.4-7 
Fibrin glue consists of homologous plasma-derived fibrin products from pooled 
donors combined with bovine thrombin and mimics the final stages of blood 
coagulation and fibrin clot formation. While the concept that fibrin glue may be 
used to strengthen the intestinal anastomosis 8;9  is certainly not new, it has not led 
to consistent and reliable data which demonstrate its effectiveness and supply 
indications for its use. So far, clinical data are mainly limited to a few observational 
reports involving anastomoses in gastric bypass patients which might indicate a 
potential benefit in terms of a reduced frequency of leakage. 10-13 Very recently,  a 
similar suggestion has been reported for stapled anastomoses during laparoscopic 
resection of rectal cancer. 14 The question still stands if the routine application of 
fibrin glue to sutured or stapled intestinal anastomoses may contribute to 
successful healing. Incidental data from preclinical studies seem to suggest that 
fibrin glue applied to patent sutured colonic anastomoses can negatively affect 
their strength. 15;16 If true, such an effect would limit the range of possible 
indications for its clinical use. In order to evaluate if fibrin glue can indeed have a 
relevant negative effect on anastomotic healing in the intestine, we conducted a 
comprehensive experimental study in the rat, examining anastomoses in both 
ileum and colon and measuring multiple parameters for wound repair on three 
different days during the early crucial phase of healing.
Methods
Experimental Design
One hundred and eight male Wistar rats weighing 250-295 g (Harlan BV, Horst, 
The Netherlands) were housed 2 per cage and accustomed to laboratory conditions 
for five days before the start of the experiment. They were randomly divided over 
6
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Biochemical analysis
After weighing, tissue samples were frozen, lyophilized and pulverized. The hydro-
xyproline content, as a measure of the collagen content, was measured by high-
performance liquid chromatography after hydrolysis with 6 N hydrochloric acid 
and coupling to dabsyl-chloride. 
Preparation of tissue extracts for gelatin zymography, using a buffer containing 
1% (v/v) Triton X-100, has been described elsewhere.18 The protein concentration of 
the extracts was measured using the bicinchoninic acid reagent. All tissue samples 
were stored at −80°C until zymography. The technique of preparation and electro-
phoresis of the gels and quantification of the various enzyme activities, which 
were expressed as arbitrary units on the basis of the lysed area, using a Sharp 
Jx-330 scanner and Imagemaster 1D software (Amersham Pharmacia, Uppsala, 
Sweden) has been described previously. 18 In-between comparison of values obtained 
on different gels was performed using collagenase type 1 (from clostridium 
histolyticum; Sigma, St. Louis, MO, USA) as an internal standard. The presence of 
true matrix metalloproteinase (MMP) activity was confirmed by adding 10 mM 
EDTA or 1,10 phenanthroline to the buffers used after electrophoresis.
Histology
The remaining 44 animals (see results), divided evenly over the groups, were killed 
as described above at 1, 3, 5 or 7 days after surgery and used for histological 
evaluation. Adhesions were dissected carefully without manipulation of the 
anastomosis, while fibrin glue was left in situ. Intestinal samples of approximately 
1 cm containing the entire anastomosis in the middle were carefully collected en 
bloc, opened at the mesenteric side, washed gently in 0.9% and spread out in a 
cassette for paraffin-embedding. From paraffin-embedded tissues, 4 μm sections 
were prepared and stained with hematoxylin and eosin (H&E). Sections were 
analyzed by using a binocular light microscope.
Another set of longitudinal sections were stained with picrosirius red to identify 
collagen fibers in the anastomotic area collagen was quantified by digital image 
analysis. 19 Images were recorded by a 3-chip CCD RGB camera (DXC-325P, Sony) 
mounted on a conventional light microscope (Axioskop, Carl Zeiss), using a 5x 
objective. Image acquisition and analysis were performed using a  complimentary 
software program (Zeiss KS 400® AxioVision 3.0). Microscopic images were digitized 
and the area positive for picrosirius red staining was recognized by segmentation 
in RGB using fixed threshold values. The anastomotic area between the two 
inverted apposite muscular layers was interactively defined on the computer 
screen. The ratio of picrosirius red positive and the total amount of pixels yielded 
the percentual area of anastomotic collagen.   
the control group (n=54) or the group where fibrin glue was applied around the 
anastomoses (n=54). All rats underwent intestinal resection and anastomoses were 
constructed in both colon and ileum. Within each group, 16 animals were 
sacrificed  on day 1, 3 and 5 after surgery and 6 animals 7 days after operation. All 
animals were observed closely and weighed daily and had free access to water and 
standard rodent chow throughout the entire experimental period (Hope Farms, 
Woerden, The Netherlands). The Animal Ethics Review Committee of the Radboud 
University Nijmegen approved the study.
Operative Procedure
Procedures were performed under semi sterile conditions using a Zeiss operation 
microscope (Carl Zeiss AG, Oberkochen, Germany). Animals were anesthetized by 
use of a mixture of isoflurane, oxygen, and nitrogen, while breathing spontaneously 
through a mask. A midline laparotomy was performed and in each rat a 1-cm segment 
was resected from the descending colon 3 cm proximal to the peritoneal reflection. 
Colonic continuity was restored by constructing an end-to-end anastomosis with 8 
single-layer, inverting, interrupted sutures (Ethilon 8-0; Ethicon, Norderstedt, Germany). 
A similar procedure was performed in the distal ileum, 15 cm proximal to the cecum. 
During operations, body temperature was kept at 38°C using a heating pad and a 
lamp. Intestines were covered with gauze pads soaked with 0.9% NaCl to minimize 
desiccation. To prevent dehydration, 10 ml of 0.9% NaCl was administered subcutaneously 
during the operation. If the animal was randomized into the fibrin glue group, 0.2 
ml of fibrin glue (Tissucol Duo 500 0.5 ml; Baxter AG, Vienna, Austria) was applied 
around the anastomosis, immediately after its completion. All rats were administered 
the analgesic buprenorphine (Temgesic, Schering Plough, Houten, the Netherlands), 
0.02 mg/kg, before operation and then every 12 hours for two days after surgery.
Wound Strength
Sixty (30 control and 30 fibrin glue) rats were killed by CO/CO
2
 asphyxiation on 
postoperative day 1, 3 or 5 and the abdomen was inspected. Segments containing 
the anastomoses were resected and adhesions were dissected carefully without 
manipulation of the anastomosis, while fibrin glue  was left in place. In order to 
measure bursting pressure, the segments were infused (2 ml/min) with 0.9% NaCl 
containing methylene blue. The maximum pressure (mm Hg) recorded immediately 
before sudden loss of pressure was taken as the bursting pressure. The site of 
rupture (within or outside the anastomotic line) was noted. Subsequently, the 
segments were placed in a tensiometer, and the breaking strength (g) was 
measured. 17 The anastomotic segment was carefully cleaned from any adhering 
tissue and fibrin glue and a 5 mm sample, containing the suture line in the middle, 
was frozen in liquid nitrogen and stored at -80 °C until further processing. 
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at day 1, 3 and 5 in the colonic anastomosis. On day 1 the fibrin glue was still 
present (lifted by the forceps on panel d) and  on day 5 there were some adhesions 
to the fibrin glue (panel f), but adhesions were also present in the control group.
Statistics
Comparison between control and experimental groups was performed using a 
two-tailed unpaired t-test or Fisher’s exact test. Comparisons within one group 
(different time points) were performed by an one-way ANOVA followed by a 
Tukey-Kramer multiple comparisons test. Results were considered statistically 
significant at p<0.05.
Results
General observations
Three animals in the fibrin glue group did not survive surgery, while one animal 
in the control group died during the first night after operation. No abnormalities 
or signs of anastomotic leakage were seen in these animals. Up to day 3 the animals 
lost approximately 10% of their pre-operative weight (Figure 1). At day 3 the rats in 
the control group started to gain weight again, while the rats in the fibrin glue 
group decreased in weight up till 4 days after surgery. As a consequence, body 
weight in the latter group was significantly (p<0.05) lower from day 3 onwards. 
At day 3, ten out of sixteen rats from the fibrin glue group showed signs of a wide 
colon filled with hardened faeces immediately proximal to the anastomosis 
(Figure 2; panel e), which nevertheless remained conductant. This phenomenon, 
which was absent in controls, was seen in only one rat at day 5 and in none of the rats 
on day 7. In addition, figure 2 represents the macroscopic findings at termination 
6
Figure 1  Postoperative course of body weight. Data represent mean (± SD) relative 
body weight, in relation to the weight prior to operation, for the control ( , n=16) 
and the fibrin glue group (, n=15). : p<0.05 vs fibrin glue group.
Figure 2  Macroscopic findings in the colonic anastomosis on day 1 (a and d), 3 (b and e) 
and 5 (c and f) in the control (left side) and fibrin glue (right side) groups.0 1 2 3 4 5
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Collagen and proteolytic activity
In the controls, but not in the fibrin glue treated animals, the hydroxyproline 
content in anastomotic segments increased significantly (p<0.001) from day 3 to 
day 5 (Figure 5). As a consequence, it was significantly lower in the fibrin glue 
group than in the control group at day 5. This effect also appeared to be present if 
collagen was quantitated histologically in the true wound area, although not 
significantly so (p=0.054 in colon) because of large inter-animal variations (Figure 6). 
Still, at 7 days no such effect was seen any more as a result of the enormous increase 
observed in the fibrin glue group. Here, mean values for collagen as percentage of 
wound surface area increased between days 5 and 7 from 4 to 29% (p=0.0002) in 
ileum and from 2 to 27% (p<0.0001) in colon, respectively.
Gelatin zymography of anastomotic extracts, obtained after 3 or 5 days, demonstrated 
the presence of multiple gelatin-degrading activities, representing proMMP-9, 
proMMP-2 and active MMP-2. No differences between the two experimental groups 
Wound Strength
The early anastomotic breaking strength remained low, but increased in both 
groups between days 3 and 5 (Figure 3). At all time points, average values in both 
groups were similar, both in ileum and colon. Anastomotic bursting pressures 
remained low at day 1 and day 3, without any differences between groups, and 
increased sharply thereafter (Figure 4). From day 3 to day 5 in the ileum, the 
average bursting pressure was increased by a factor 3.17 (p<0.001) and 2.85 
(p<0.001) in the controls and fibrin glue treated animals, respectively. In the colon 
these factors were 2.44 (p<0.001) and 2.51 (p<0.001), respectively. However, at day 5 the 
bursting pressure in the fibrin glue group remained below that in the controls, 
although only significantly (p=0.0138) so in the ileum. Only at day 5 some bursting 
sites were outside the suture line (Figure 4).   
6Figure 3  Anastomotic breaking strength. Data represent mean and SD for strength in ileal (A) and colonic (B) anastomoses from the control groups (white bars) and the groups which received fibrin glue (grey bars). #: p<0.05 vs day 3.
Figure 4  Anastomotic bursting pressure. Individual values and medians (horizontal 
bars) are given for ileal (A) and colonic (B) anastomoses in both control (C) and fibrin 
glue (FG) groups.  The bursting site was either within ( ) or outside ( ) the suture 
line. : p<0.05; #: p<0.05 vs day 3.
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Discussion
Anastomotic leaks are detected anywhere from 3 to 45 days postoperatively and 
the diagnosis is mostly made between days 6 and 9 20 or even later. 21 However, it 
stands to reason that the processes which lead to failure start much earlier, 
probably in the immediate postoperative period when wound strength is believed 
to be low. The incidence and severity of the complication being as they are, it seems 
logical and even necessary to seek ways to protect anastomotic integrity. There 
exists a renewed interest in staple or suture line reinforcement3 by topically 
applied sealants, which is also reflected in recent preclinical studies. 22-25
Fibrin sealant is a well established tool with multiple FDA-approved indications 
which are ever expanding. 9 Although its potential is often suggested, the application 
of fibrin glue to strengthen anastomoses in the gastrointestinal tract has not 
become common practice. Mostly, its reported clinical application in gastrointestinal 
were found, with the exception of proMMP-9 in the ileum at day 3, where it was 
higher (p=0.003) in the fibrin glue group than in the controls (data not shown). 
Histology
Typical examples of colonic anastomoses are presented in Figure 7. No obvious or 
consistent differences in microscopic wound architecture were seen between 
groups. Fibrin glue was clearly present in the experimental group at day 3. At day 7, 
the fibrin glue appeared to be mostly gone. The same was observed in the ileum 
(not shown). 6
Figure 5  Hydroxyproline content of anastomotic segment.  Bars represent mean 
and SD in ileal (A) and colonic (B) segments from the control groups (white bars) 
and the groups which received fibrin glue (grey bars). : p<0.05 vs controls; #: p<0.05 
vs day 3.
Figure 6  Wound collagen. Bars represent mean and SD in ileal (A) and colonic 
(B) segments from the control groups (white bars) and the groups which received 
fibrin glue (grey bars). #: p<0.05 vs day 5.
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the existing submucosal layer while restoration of original tissue strength depends 
on the deposition of newly-made collagen fibrils. Interestingly, the application of 
fibrin glue appears to result in a reduced hydroxyproline content and a lessened 
presence of collagen fibrils in anastomotic segments at day 5. This phenomenon 
may explain the somewhat lower bursting pressures observed, although apparently 
sufficient collagen is still synthesized to cause wound strength to increase strongly 
between days 3 and 5. Also, this is a transient phenomenon, since one week after 
operation wound collagen deposition is similar in both groups. It is presently 
unknown how fibrin glue around the anastomosis would cause the slight delay in 
wound collagen formation, since fibrin is believed to be an excellent template for 
cellular migration. 28
The bursting pressure is a parameter for anastomotic strength only if the bursting 
site is within the suture line, which will mostly not be the case anymore at day 7 
after operation. For that reason, and the fact that no differences in breaking 
strength are seen between groups up until day 5, we only assessed histology after 
7 days. 
The present data extend earlier, limited, findings where significant loss of colonic 
bursting pressure was described at days four 16 and five 15 after surgery. In our 
study the bursting pressure at day 5 is still quite high and much elevated compared 
to day 3. Still, a certain delay in recovery of intestinal strength cannot be denied, 
while wound strength during the first three days appears unaffected. Altogether, 
the available evidence indicates fibrin glue not to be beneficial, and at its best 
irrelevant, to anastomotic healing in the intestine.
The conclusion must therefore be that there is no justification for using fibrin glue 
on patent anastomoses constructed under low-risk conditions. It remains to be 
determined if it can play a beneficial role in other situations. In a very recent study 
on partial colonic anastomoses constructed with a limited number of sutures, a 
positive effect of fibrin glue was observed on the anastomotic bursting pressure at 
days 3 and 5 after operation. 29 Clinically, its application over stapled anastomoses 
during laparoscopic resection of rectal cancer has been reported, where a declining 
tendency of the anastomotic leakage was suggested. 14  Thus, it may be that it can 
play a protective role under conditions where chances for anastomotic leakage are 
enhanced. Under those conditions, its potential benefit may outweight its unwanted 
effects.
surgery seems to be limited to bariatric surgery 13 and treatment of fistulae. 26;27 
One question which needs an answer is if the application of fibrin glue, as a precaution 
against leakage, could be indicated for all intestinal anastomoses.
The present experimental data show fibrin glue to be not entirely without harm  if 
applied to intestinal anastomoses. Application of fibrin around patent anastomoses 
in both ileum and colon transiently affects repair. This effect presents clinically 
by a temporary and resolving ileus and a delayed weight gain and experimentally 
by a delay in collagen deposition in the true anastomotic area, which may cause 
the transient and relatively minor reduction in anastomotic bursting pressure.
Loss of body weight, always observed after operation, is more quickly compensated 
in the control group. In the fibrin glue group signs of a wide colon, filled with 
hardened faeces, just proximal of the anastomosis are seen on day 3, but not 
anymore at day 5. Possibly, fibrin glue can interfere with peristaltic movement of 
the bowel which leads to transient constipation in the large bowel only, because 
the consistency of the faeces is different from the small bowel. Interestingly, ileus 
was also described after the application of collagen fleece which was kept in place 
by fibrin glue. 25 Early wound strength depends on the suture-holding capacity of 
6
Figure 7  Anastomotic histology in the colon. Each panel shows a tissue segment 
with the anastomosis in the middle and the mucosal layer at the bottom at a 
magnification of approximately x 40, representing typical examples obtained at 
day 3 (a: control and b: fibrin glue) and day 7 (c: control and d: fibrin glue). The 
asterisk () denotes fibrin.

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b d
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Abstract
Background Since leakage of intestinal anastomoses is associated with high 
morbidity and mortality, protecting anastomotic integrity and finding ways to 
minimize, postpone or prevent the consequences of feacal spill in the abdominal 
cavity remain important goals for ongoing research. The value of two frequently 
used fibrin-based sealants in protecting anastomotic integrity was investigated in 
a recently developed model where the analgesic carprofen induces leakage of 
patent anastomoses in the rat ileum.
Methods In 110  Wistar rats an anastomosis was constructed in the ileum. In 
experiment 1, where 20 animals were divided over a control (n=10) and a fibrin 
glue group (n=10), all rats were administered carprofen (5mg/kg/day) starting prior 
to surgery. In experiment 2 the rats were divided over two groups (n=45) which 
received either carprofen (1.25 mg/kg/day) starting prior to surgery (group 2A) or 
starting 24 h after surgery (group 2B) in a dosage of 5 mg/kg/day. Both group 2A 
and 2B were divided into a control (n=15), a fibrin glue (n=15) and a fibrin coated 
patch (n=15) group. The animals in  experiment 1 and experiment 2A were 
sacrificed at day 3 and those in experiment 2B at day 4.
Results In experiment  1 anastomotic leakage rates, ileus and wound strength did 
not significantly differ between groups. In experiment 2A ileus was significantly 
more frequently present in the fibrin glue (p=0.02) and the fibrin coated patch 
group (p<0.001) compared to the control group, but anastomotic leakage rates and 
wound strength were similar. In experiment 2B the bursting pressure was 
significantly lower in the fibrin glue  (p<0.001) group (p<0.01) than in the control 
group. Anastomotic leakage rates were elevated in the fibrin glue group, although 
not significantly so. 
Conclusions Protecting anastomotic integrity must remain an import goal of 
ongoing research to lower morbidity and mortality rates. In this study, sealing the 
high-risk anastomosis with fibrin glue or a fibrin coated patch does not lower leakage 
rates and causes ileus and therefore these measures should be treated witch caution.
Introduction
Anastomotic failure remains the single most important hazard within gastroin-
testinal surgery. A leaking anastomosis is associated with increased morbidity and 
considerable mortality. 1;2 Protecting the anastomotic integrity and finding ways 
to minimize, postpone or prevent the consequences of leakage therefore remain 
important goals of ongoing research. Even a temporary protection would probably 
be valuable. Delaying leakage of intestinal contents into the peritoneal space until 
the patient has recovered to some extent from the operation would probably 
enhance the capacity to deal with a second event. In theory it seems logical to 
apply some kind of seal around the anastomosis to minimize, prevent or postpone 
leakage. 
Fibrin based sealants are increasingly used in different fields of surgery to provide 
a sealing barrier, to induce hemostasis or to bond tissue together. 3-6 Two frequently 
used seals are fibrin glue and  fibrin-thrombin coated fleece, which both consists 
of homologous plasma-derived fibrin products from pooled donors combined with 
bovine thrombin, thus mimicking the final stages of blood coagulation and fibrin 
clot formation. The potential benefit of suture or staple line reinforcement with 
these type of products needs investigation. 7
The clinical application of fibrin glue around a gastrointestinal anastomosis seems 
to be mainly limited to gastric bypass surgery where it is suggested, but not proven, 
to reduce the leakage rate. 8-10 While data from some preclinical studies imply that 
fibrin glue can negatively affect anastomotic strength 11-13, we found no compelling 
reason why its efficacy in protecting high-risk anastomoses should not be investigated 
further. 14 Most data on the use of a fibrin-thrombin coated fleece  in gastrointestinal 
surgery are preclinical and concern esophageal 15, colonic 16 and ileal 17 anastomoses. 
It was suggested to be safe and to even strengthen the anastomosis.
It appears especially worthwhile to investigate the effects of suture line reinforcement 
if anastomoses are to be constructed under conditions where chances for leakage 
are high. Very recently, we described a model in the rat where a complete and patent 
ileal anastomosis develops signs of dehiscence during the first three days after 
construction. 18 
The current study aims to determine if leakage of such high-risk anastomoses can 
be prevented by peroperative suture line sealing with fibrin glue or a fibrin coated 
patch.
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segment was resected  in the distal ileum, 15 cm proximal to the cecum. Ileal 
continuity was restored by constructing an end-to-end anastomosis with 8 
single-layer, inverting, interrupted sutures (Ethilon 8-0; Ethicon, Norderstedt, 
Germany).  During operations, body temperature was kept at 38°C using a heating 
pad and a lamp. Intestines were covered with gauze pads soaked with 0.9% NaCl to 
minimize desiccation. To prevent dehydration, 10 ml of 0.9% NaCl was administered 
subcutaneously during the operation.
Methods
Experimental Design
Altogether 110 male Wistar rats weighing 250-295 g (experiment 1: n=20 from 
Harlan BV, Horst, The Netherlands; experiment 2: n=90 from Charles River, Sulzfeld, 
Germany) were housed 2 per cage and accustomed to laboratory conditions for five 
days before the start of the experiment. All rats underwent intestinal resection 
and an anastomosis was constructed in the ileum. Postoperative development of 
anastomotic leakage depended on the administration of carprofen. 18 All animals 
were observed closely and weighed daily and had free access to water and standard 
rodent chow (Hope Farms, Woerden, The Netherlands) throughout the entire 
experimental period. The Animal Ethics Review Committee of the Radboud 
University Nijmegen approved the study.
In experiment 1, 20 rats were randomly divided over a control group (n=10) and a 
group (n=10) where  fibrin glue was applied to the anastomosis. The animals received 
carprofen from the day of operation and were sacrificed at day 3 (Table 1).
In experiment 2, ninety rats were randomly divided over experiment A or B, each 
consisting of three groups: a control group (n=15) and groups (n=15 each) where the 
anastomosis was reinforced with fibrin glue or a fibrin-thrombin coated patch, 
respectively. The animals in experiment A received carprofen (low dose, see below) 
from the day of operation and were sacrificed at day 3. In experiment B the animals 
received carprofen from the first postoperative day and they were sacrificed at day 4 
(Table 2).  
Analgesia and operative procedure
All rats in experiment 1 were administered carprofen (Rimadyl, Pfizer Animal 
Health, Capelle aan de IJssel, the Netherlands) in a dosage of 5 mg/kg subcutaneously 
before operation and 24 h and 48 h after surgery.
All rats in experiment 2 were administered buprenorphine (Temgesic, Schering 
Plough, Houten, the Netherlands), 0.02 mg/kg subcutaneously, before operation 
and then every 12 h for two days after surgery. Next to the buprenorphine, the 
animals in experiment 2A were also administered carprofen in a low dose, 1.25 
mg/kg, prior to operation and 24 h and 48 h later. The animals in experiment 2B 
received carprofen in a dosage of 5 mg/kg every 24 h (three times in total), starting 
24 h after surgery.
Procedures were performed under semi sterile conditions using a Zeiss operation 
microscope (Carl Zeiss AG, Oberkochen, Germany). Animals were anesthetized by 
use of a mixture of isoflurane, oxygen, and nitrogen, while breathing spontaneously 
through a mask. A midline laparotomy was performed and in each rat a 1-cm 
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Table 1  Experiment 1
Experiment 1 control fibrin glue 
analgesia carprofen 5 mg/kg prior to surgery 
group size 10 10
premature death (day) 1 (3) 4 (3)
day of sacrifice 3
anastomotic leakage 8 6
ileus 3 4
Table 2  Experiment 2
Experiment 2  A  B
analgesia carprofen 1.25 mg/kg 
starting prior to surgery
carprofen 5 mg/kg starting 
24 h after surgery 
group control fibrin 
glue 
fibrin 
coated 
patch 
control fibrin 
glue
fibrin 
coated 
patch
group size 15 15 15 15 15 15
premature death (day) 0 2 (3,3) 2 (4,4) 1 (3) 2 (2,2) 7* (2, 3, 
3, 3,  
3, 2, 2)
day of sacrifice 3 4
anastomotic leakage 4 4 6 4 10 6
ileus 0 6 * 11* 3 5 9
After termination, at most 12 animals in experiment 2 in each group were analysed for wound 
strength and, where possible, the remaining animals for histology. * p<0.05  vs controls (Fisher’s two-
sided test).
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Necropsy and analysis of wound repair
All rats were killed by CO/CO
2
 asphyxiation. The abdomen was inspected and all 
findings were recorded, especially signs of anastomotic leakage like dehiscence of the 
anastomosis, the presence of feacal spill or a puncture in the anastomotic line with or 
without an abscess near it. Also, the presence of severe adhesions and ileus were noted.
Where possible, segments containing the anastomosis were resected and adhesions 
were dissected carefully without manipulation of the anastomosis, while any 
sealing material was left in place. In order to measure bursting pressure, the 
segments were infused (2 ml/min) with 0.9% NaCl containing methylene blue. The 
maximum pressure (mm Hg) recorded immediately before sudden loss of pressure 
was taken as the bursting pressure. The site of rupture (within or outside the 
anastomotic line) was noted. Subsequently, the segments were placed in a 
tensiometer, and the breaking strength (g) was measured. 19
In a number of animals from experiment 2 (Table 2) tissue was used for histological 
analysis. Intestinal samples of approximately 1 cm containing the entire anastomosis 
in the middle were carefully collected en bloc, opened at the mesenteric side, 
washed gently in 0.9% and spread out in a cassette for paraffin-embedding. From 
paraffin-embedded tissues, 4 μm sections were prepared and stained with hema- 
toxylin and eosin (H&E).  
Statistics
Differences relating to dichotomous variables were analysed by a (two-tailed) 
Fisher’s exact test (two groups) or a Chi-square test (three groups). Comparison of 
continuous variables was performed using a two-tailed unpaired t-test or 
Mann-Whitney test (two groups) or a One-way Analysis of Variance (ANOVA) 
followed by a Tukey-Kramer post test (three groups). Results were considered 
statistically significant at p<0.05. 
Results
Experiment 1
Postoperative weight loss was around 10% at day 3 and similar in the two groups. 
One rat died prematurely on day 3 in the control group due to ileal dehiscence and 
feacal spill. In the fibrin glue group four rats died prematurely on day 3, two of 
these exhibited signs of anastomotic leakage. In these two animals wound strength 
was measured because their death occurred immediately prior to the planned 
time of sacrifice. Altogether, anastomotic leakage was seen in eight rats in the 
control group and six rats in the fibrin glue group. Ileus was observed in three rats 
from the control group and four rats from the fibrin glue group (Table 1).
If the animal was randomized into a fibrin glue group in either experiment 1 or 2, 
0.2 ml of fibrin glue (Tissucol Duo 500 0.5 ml; Baxter AG, Vienna, Austria) was 
applied around the anastomosis, immediately after its completion (Figure 1a). If 
the animal was randomized into the fibrin-thrombin coated fleece group in 
experiment 2, a  0.5 cm wide fibrin-trombin coated collagen patch (TachoSil, Nycomed, 
Zurich, Switserland) was moistened and wrapped around the anastomosis immediately 
after its completion without compressing the diameter (Figure 1d). After two 
minutes the ileum was placed back in the abdominal cavity and the abdominal 
wall was closed with a running suture (Vicryl 3-0; Ethicon, Norderstedt, Germany). 
The skin was closed with staples.
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Figure 1  Macroscopic findings. Left panel: a) fibrin glue around the anastomosis just 
after surgery; b) normal aspect after 3 days; c) feacal spill due to a dehiscent anastomosis. 
Right panel: d) a fibrin coated patch applied around the anastomosis; e) normal aspect 
after three days; f) ileus where the intestine proximal to the anastomosis is filled and 
distended and the intestine distal to the anastomosis is small and relatively empty.
a d
b e
c f
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Experiment 2A
The mean relative weight at day 3 (compared to pre-operative values) was 93.2 ± 0.7 
(SD) % in the control group. Weights were significantly (p<0.0001, ANOVA) lower in 
both the fibrin glue (90.0 ± 0.6 %, p<0.05 at post test) and the fibrin coated patch 
(89.3 ± 0.5 %, p<0.05) groups. 
Two rats died prematurely in each experimental group: only one of these (from the 
fibrin coated patch group) showed signs of anastomotic leakage. However the 
fibrin coated patch that was applied contained the feacal spill. The other rats died 
of ileus (Figure 1f) Leakage rates in the groups with suture line reinforcement 
were not significantly different from that in controls. Ileus was more frequently 
observed in the fibrin glue (p=0.0169) and the fibrin coated patch (p<0.0001) groups 
than in the control group where it was absent (Table 2).
Neither anastomotic bursting pressure nor breaking strength were significantly 
different in the three groups (Figure 3A, B). Typical examples of ileal anastomoses 
are presented in Figure 4. No obvious or consistent differences in microscopic 
On day 3 the wound strength was similar in the ileal  anastomoses from both 
groups. The median bursting pressure was 0 mm Hg in both groups. Median 
breaking strength (with range) was 21 (0-62) g in controls and 0 (0-24) g in the 
fibrin glue group. The breaking strength in the latter group could only be measured 
in seven rats,  because two died prematurely and one anastomosis was completely 
disrupted by the bursting pressure measurement (Figure 2).
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Figure 2  Anastomotic bursting pressure and breaking strength in experiment 1. 
Individual values for the bursting pressure (panel A) and the breaking strength (panel B) in 
the control and the fibrin glue group. Horizontal bars indicate median, if no horizontal 
bar is present median value is zero. The bursting site was always within the suture line. 
Since two rats in the fibrin glue group died immediately prior to scheduled termination, 
wound strength could still be measured.
Figure 3  Anastomotic bursting pressure and breaking strength in experiment 2. 
Panels A and B depict individual values and means (red horizontal bars) for the 
bursting pressure in the control, fibrin glue and fibrin coated patch groups of 
experiment 2A (panel A) and 2B (panel C). The bursting site was always within the 
suture line. In panel B (experiment 2A) and D (experiment 2B) data represent mean 
and SEM for breaking strength in the three groups. * p<0.0001 vs controls (two-
tailed Mann-Whitney test).
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In the control group, one rat died of ileus. Two rats died prematurely in the fibrin 
glue group, both of ileal dehiscence (Figure 1c). In the fibrin coated patch group 
seven rats died prematurely (p=0.0352 vs the control group). None of them 
displayed signs of anastomotic leakage, but all showed signs of ileus. Altogether 
nine rats (60 %) had an ileus in the fibrin coated patch group, which frequency was 
higher, but not significantly so, than in both other groups.The anastomotic leakage 
rate was highest (67%) in the fibrin glue group, but differences with the fibrin 
coated patch (40%) and control (27%) groups remained non-significant (Table 2).
Due to premature mortality and technical problems, anastomotic bursting 
pressure and breaking strength in the fibrin coated patch group could only be 
measured in two and one rat, respectively.
The mean bursting pressure on day 4 was significantly (p<0.0001) lower in the 
fibrin glue group  (24 ± 8 (SEM) mm Hg than in the control group (134 ± 15 mm Hg). 
No such difference was observed for the anastomotic breaking strength (Figure 
3C,D)
Discussion
In theory, reinforcement of the suture line in high-risk anastomoses may reduce 
the frequency of anastomotic leakage. In practice, in this particular animal model, 
neither fibrin glue nor a fibrin coated patch reduces the leakage rate of ileal 
anastomoses. They even increase postoperative complications and, in case of the 
patch, mortality.
Any method which prevents peritonitis to occur, or minimizes or even postpones 
the deleterious effects of anastomotic dehiscence, constitutes enormous progress. 
For this purpose, two frequently used, fibrin-based,  sealants have been examined, 
using a new model for anastomotic leakage. So far, this type of experiments have 
been performed in models where anastomotic dehiscence is induced by creation of 
an iatrogenic defect, mostly by using an insufficient number of sutures. 20;21 In the 
present model, peri-operative use of carprofen induces dehiscence with time of a 
patent anastomosis in the rat ileum. 18 By altering the dosage and timing of 
administration of carprofen it is possible to create less abundant feacal spill 
(unpublished data). Although the mechanisms responsible remain to be elucidated, 
we believe the model to be clinically more relevant than those where a suture line 
defect is created on purpose during surgery.
It has been suggested that fibrin glue applied to patent sutured colonic anastomoses 
can negatively affect their strength. However, in a previous study we have found 
fibrin glue not to have any clinically relevant effect on the early healing of 
intestinal anastomoses. 14 
wound architecture were seen between groups. Fibrin glue and the fibrin coated 
patch were present and marked in the figures.
Experiment 2B
At day 4 the mean values for relative weight were 92.1 ± 3.8 % in the controls and 
86.9 ± 2.2 (p<0.001) and 86.8 ±1.3 % (p<0.001) in the fibrin glue and fibrin coated 
patch groups, respectively. 
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Figure 4  Anastomotic histology in the ileum of experiment 2A. Each panel shows a 
tissue segment with the anastomosis in the middle and the mucosal layer at the bottom 
at a magnification of 50x, representing typical examples obtained at day 3. Panel a: 
control,  panel b: fibrin glue and panel c: fibrin coated patch. The asterisk (*) denotes 
fibrin glue and the hatch (#) denotes the fibrin coated patch.
*
# # 
a
b
c
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constitute a warning against the random application of such seals around intestinal 
anastomoses. Since anastomotic leakage remains such a severe complication after 
gastro-intestinal surgery, the search for an effective seal around the anastomosis 
that prevents leakage without causing complications must remain an important 
goal for ongoing research.
The current study shows no advantage of the application of fibrin glue around the 
high-risk ileal anastomosis. It does not reduce anastomotic leakage rates. On the 
contrary, in experiment 2B, it even seems to increase them, although not 
significantly so (Table 2). Another important finding is that fibrin glue appears to 
correlate with ileus, particularly in experiment 2A. The peristaltic movement of 
the bowel can be decreased once a rigid glue clot is formed on the anastomosis and 
the area around it. Such a phenomenon may also explain the additional weight 
loss in the fibrin and fibrin coated patch groups. Since the rat is not capable of 
vomiting it just stops eating and loses weight. This effect has been previously 
found by Chmelnik 22 who made an insufficient ileo-ileal anastomosis in rats and 
found severe preanastomotic dilatation after wrapping it with a fibrin coated 
patch. Indeed, when a fibrin coated patch was applied in our study ileus rates were 
even higher. In experiment 2B, all premature deaths in the fibrin coated patch 
group were the result of ileus and not of anastomotic leakage. Although anastomotic 
leakage rates are not significantly reduced by applying the fibrin coated patch, 
there were two cases in which the patch prevented the feacal content from leaking 
into the abdominal cavity.
Pantelis 16 wrapped a fibrin coated patch around an incomplete colonic anastomosis 
in mice and reports less anastomotic leakage without mentioning ileus rates. 
Perhaps the colonic wall is more firm and therefore less prone to compression of 
the lumen than the ileal wall.  However, in a previous study where fibrin glue was 
applied around a colonic anastomosis, we also found the rats to suffer from colonic 
ileus. 14 In addition, Schreinemacher finds a collagen fleece, which is kept in place 
around a colonic anastomosis with fibrin glue, to induce bowel obstruction and 
not to improve healing. 23 
Nordentoft 17 tested a fibrin coated patch around a patent anastomosis in the small 
intestine of a pig and reports no difference in degree of stenosis, but also no 
differences in healing compared to the control anastomosis. 
Recently clinical studies using a fibrin coated patch have been published. Wrapping 
a fibrin coated patch around a colonic anastomosis is feasible and well tolerated. 24 
A very small series describes less anastomotic leakage and a shorter hospital stay 
when a fibrin coated patch is used. 25 In addition, there is one clinical report on 
pancreatic surgery 26 showing promising results in reducing leakage.
Tissue adhesives and glues have already proven to be very useful in different fields 
of surgery to promote tissue, union,  sealing, hemostasis and wound healing. 
Despite their multi-faceted use they are not frequently used in gastro-intestinal 
surgery.  This study finds fibrin glue and a fibrin coated patch not to be useful if 
applied around a leakage-prone anastomosis. Obviously, one should keep in mind 
that the results stem from an experimental model where the exact mechanism 
that induces leakage to occur remains unknown. Still, the adverse events observed 
7
114 115
(23)  Schreinemacher MH, Bloemen JG, van der Heijden SJ, Gijbels MJ, Dejong CH, Bouvy ND. Collagen 
fleeces do not improve colonic anastomotic strength but increase bowel obstructions in an 
experimental rat model. Int J Colorectal Dis 2011; 26(6):729-735.
(24)  Parker MC, Pohlen U, Rinkes IH, Delvin T. The application of TachoSil(R) for sealing colorectal 
anastomosis: a feasibility study. Colorectal Dis 2012.
(25)  De Stefano A, Bettarini F, Di MG, Neri A. [Enteric anastomosis and Tachosil(R)]. Minerva Chir 2011; 
66(3):183-188.
(26)  Pozzo G, Amerio G, Bona R, Castagna E, Parisi U, Sorisio V et al. A new method of jejunal 
reconstruction after pancreaticoduodenectomy. Hepatogastroenterology 2010; 57(102-103):1305-1308.
Reference List
(1)  Alves A, Panis Y, Trancart D, Regimbeau JM, Pocard M, Valleur P. Factors associated with clinically 
significant anastomotic leakage after large bowel resection: multivariate analysis of 707 patients. 
World J Surg 2002; 26(4):499-502.
(2)  Bruce J, Krukowski ZH, Al-Khairy G, Russell EM, Park KG. Systematic review of the definition and 
measurement of anastomotic leak after gastrointestinal surgery. Br J Surg 2001; 88(9):1157-1168.
(3)  Chalmers RT, rling Iii RC, Wingard JT, Chetter I, Cutler B, Kern JA et al. Randomized clinical trial of 
tranexamic acid-free fibrin sealant during vascular surgical procedures. Br J Surg 2010; 97(12):1784-
1789.
(4)  Mooney E, Loh C, Pu LL. The use of fibrin glue in plastic surgery. Plast Reconstr Surg 2009; 124(3):989-992.
(5)  Patel S, Rodriguez-Merchan EC, Haddad FS. The use of fibrin glue in surgery of the knee. J Bone Joint 
Surg Br 2010; 92(10):1325-1331.
(6)  Yoo J, Chandarana S, Cosby R. Clinical application of tissue adhesives in soft-tissue surgery of the 
head and neck. Curr Opin Otolaryngol Head Neck Surg 2008; 16(4):312-317.
(7)  Abbas MA. Anastomotic leak: should we continue to accept the risks? Dis Colon Rectum 2010; 
53(6):859-860.
(8)  Liu CD, Glantz GJ, Livingston EH. Fibrin glue as a sealant for high-risk anastomosis in surgery for 
morbid obesity. Obes Surg 2003; 13(1):45-48.
(9)  Sapala JA, Wood MH, Schuhknecht MP. Anastomotic leak prophylaxis using a vapor-heated fibrin 
sealant: report on 738 gastric bypass patients. Obes Surg 2004; 14(1):35-42.
(10)  Silecchia G, Boru CE, Mouiel J, Rossi M, Anselmino M, Tacchino RM et al. Clinical evaluation of 
fibrin glue in the prevention of anastomotic leak and internal hernia after laparoscopic gastric 
bypass: preliminary results of a prospective, randomized multicenter trial. Obes Surg 2006; 
16(2):125-131.
(11)  Houston KA, Rotstein OD. Fibrin sealant in high-risk colonic anastomoses. Arch Surg 1988; 123(2):230-234.
(12)  van der Ham AC, Kort WJ, Weijma IM, van d, I, Jeekel J. Effect of fibrin sealant on the healing colonic 
anastomosis in the rat. Br J Surg 1991; 78(1):49-53.
(13)  Li Y, Bao Y, Jiang T, Tan L, Gao Y, Li J. Effect of the combination of fibrin glue and growth hormone 
on incomplete intestinal anastomoses in a rat model of intra-abdominal sepsis. J Surg Res 2006; 
131(1):111-117.
(14)  van der Vijver RJ, van Laarhoven CJ, de Man BM, Lomme RM, Hendriks T. The effect of fibrin glue on 
the early healing phase of intestinal anastomoses in the rat. Int J Colorectal Dis 2012; 27(8):1101-1107.
(15)  Verhage RJ, Ruiz A, Verheem A, Goldschmeding R, Borel R, I, van HR. Fibrin-thrombin coated 
sealant increases strength of esophagogastric anastomoses in a rat model. J Surg Res 2012.
(16)  Pantelis D, Beissel A, Kahl P, Wehner S, Vilz TO, Kalff JC. The effect of sealing with a fixed 
combination of collagen matrix-bound coagulation factors on the healing of colonic anastomoses 
in experimental high-risk mice models. Langenbecks Arch Surg 2010; 395(8):1039-1048.
(17)  Nordentoft T, Romer J, Sorensen M. Sealing of gastrointestinal anastomoses with a fibrin glue-coated 
collagen patch: a safety study. J Invest Surg 2007; 20(6):363-369.
(18)  van der Vijver RJ, van Laarhoven CJ, de Man BM, Lomme RM, Hendriks T. Perioperative Pain Relief 
by a COX-2 Inhibitor Affects Ileal Repair and Provides a Model for Anastomotic Leakage in the 
Intestine. Surg Innov 2012.
(19)  de Waard JW, Wobbes T, de Man BM, van der Linden CJ, Hendriks T. Post-operative levamisole may 
compromise early healing of experimental intestinal anastomoses. Br J Cancer 1995; 72(2):456-460.
(20)  Komen N, van der Wal HC, Ditzel M, Kleinrensink GJ, Jeekel H, Lange JF. Colorectal anastomotic 
leakage: a new experimental model. J Surg Res 2009; 155(1):7-12.
(21)  Nordentoft T, Sorensen M. Leakage of colon anastomoses: development of an experimental model in 
pigs. Eur Surg Res 2007; 39(1):14-16.
(22)  Chmelnik M, Lasch L, Weih S, Wink E, Romero P, Holland-Cunz S. Anastomotic sealing with a 
fibrin-coated collagen patch in small-diameter bowel. Langenbecks Arch Surg 2011; 396(5):685-691.
7
summary and future directions
118 119
Summary
A leaking intestinal anastomosis is a relatively frequent disaster associated with 
increased morbidity and considerable mortality. Many clinical and preclinical 
studies have aimed to identify risk factors for impaired anastomotic healing, but 
the finding that anastomotic leakage may take place in the absence of any currently 
known risk factor illustrates that much remains to be learned. In this respect very 
little attention has been paid to the analgetics that are frequently used periopera-
tively. In addition, recently there exists renewed interest in the possibilities of 
suture line reinforcement as a means to prevent anastomotic leakage or to contain 
is effects.
The background for the studies described hereafter is outlined in chapter 1. All 
studies have been performed in a well established rat model suitable for the 
assessment of anastomotic healing in the intestine. Primary outcome measurements 
for wound repair are wound strength,  measured as bursting pressure and breaking 
strength, and anastomotic leakage. In addition, collagen levels are measured and 
wound histology is examined.
Paracetamol is widely used for pain relief after surgical interventions. Its potential 
effects on soft tissue repair have hardly been investigated. Chapter 2 describes the 
first study into the effect of paracetamol on early healing of intestinal anastomoses 
and abdominal fascia. In 78 rats an anastomosis was constructed in both ileum 
and colon. The rats received either a low or a high dose (50 or 200 mg/kg/day, 
respectively, divided over two doses) paracetamol or vehicle (controls) until they 
were killed on day 3 or 7 after surgery. No significant differences were found 
between control and paracetamol-treated groups at any time point for any of the 
parameters investigated. Wound strength increased significantly from day 3 to 
day 7 in all groups, both in anastomoses and in the fascia. No differences in 
collagen levels were found nor did histology indicate the presence of gross 
differences between groups. This study suggests that paracetamol can be given 
safely to patients for postoperative analgesia after gastrointestinal surgery.
Next to paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs) are important 
constituents of protocols for postoperative pain relief. There is an emerging 
consciousness that perhaps their use may not be without consequences for the repair 
sequence, particularly the inflammatory phase. Chapter 3 reports on a study into 
the effects of the NSAIDs diclofenac and naproxen. An anastomosis was constructed 
in both colon and ileum of 104 rats. They were divided into groups who received 
either diclofenac (4 mg/kg/day) or naproxen (10 mg/kg/day) daily from the day of 
surgery or from day 3 after surgery. Animals were killed on day 3 or day 7.
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Chapter 5 describes experiments to further characterize the previously mentioned 
negative effects of carprofen on early anastomotic healing. In 159 rats an 
anastomosis was constructed in the ileum. In experiment 1 eighty-four rats were 
divided over control and experimental groups, which received daily buprenorphine 
or carprofen, respectively, as an analgesic and were killed on day 1, 2 or 3 after 
surgery. In experiment 2 three groups of 15 rats received carprofen daily either 
immediately after surgery or with a delay of 1 or 2 days. Animals were killed after 
3 days of carprofen administration. In experiment 3 three groups of 10 rats 
received different doses (full, half or quarter) of carprofen daily from surgery. 
Animals were killed after 3 days.
In significant contrast to buprenorphine, which never did so, carprofen induced 
frequent signs of anastomotic leakage, which were already present at day 1. If first 
administration was delayed for 48 hours, the leakage rate was significantly 
reduced (from 80 to 20%; p=0.0028). Throughout the study, the anastomotic 
bursting pressure was lowest in animals who displayed signs of anastomotic 
leakage. Loss of anastomotic integrity did not coincide with reduced levels of 
hydroxyproline or increased activity of matrix metalloproteinases. Thus, we 
conclude that carprofen interferes with wound healing in the rat ileum at a very 
early stage. If it does not kill the animal, at least it renders it more vulnerable to 
second hits after initial surgery. 
Although the mechanisms responsible remain to be fully understood, there 
appears to be an increasing body of evidence which suggests that one should be 
aware that NSAIDs may affect the outcome of the wound healing sequence.
In theory, it seems logical to apply some kind of seal around the anastomosis to 
prevent leakage. Very recently, it has been emphasized again that the potential 
benefits of such suture or staple line reinforcement need investigation. While the 
concept that fibrin glue may be used to strengthen the intestinal anastomosis is 
certainly not new, it has not yet led to consistent and reliable data which 
demonstrate its effectiveness and supply indications for its clinical use. Incidental 
data from preclinical studies seem to suggest that fibrin glue applied to patent 
sutured colonic anastomoses can negatively affect their strength.
Therefore, the effects of applying fibrin glue around a normal intestinal anastomosis 
have been carefully examines and the results are reported in chapter 6. In 108 rats 
an anastomosis was constructed in the ileum and colon. In half, fibrin glue was 
applied around anastomoses. Animals were killed at day 3, 5 or 7. A transient 
colonic ileus was observed in the experimental group. Anastomotic breaking 
strength was always similar in both the control and fibrin glue groups. Anastomotic 
bursting pressures remained low at days 1 and 3, without any differences between 
the groups. In both groups, the bursting pressure increased sharply (p<0.001) 
Anastomotic leakage in the ileum (p<0.0001) and mortality rates (p=0.001) were 
significantly increased in the diclofenac group. On day 7 the anastomotic bursting 
pressure in the ileum remained below that of the controls in the diclofenac and 
naproxen treated rats. When administration of diclofenac was postponed to day 3 
after surgery, anastomotic dehiscence was almost absent. The colonic anastomosis 
and abdominal wall always remained unaffected. This study implies that 
administration of diclofenac immediately after intestinal surgery strongly affects 
ileal anastomotic healing in the rat. This effect is also observed for naproxen, 
although to a much lesser extent.  Interestingly when drug administration is 
withheld for three days these complications are prevented. NSAIDs differ in their 
selectivity for COX-1 and COX-2, Diclofenac is reported to be far more selective for 
COX-2 than naproxen. 
Although the more selective NSAIDs may be preferred for their supposed lack of 
side effects, one should realize that this is more relevant for chronic users. In the 
short postoperative period it is more important to choose an analgesic drug that 
does not interfere with the healing process. 
Earlier work from our laboratory and the data reported in chapter 3 indicate that 
NSAIDs with a preference for COX-2 inhibition may induce anastomotic failure in 
small bowel anastomoses. This suggests that controlled application of a suitable 
drug from this class might result in reproducible leakage rates, without excessive 
mortality, in initially patent small bowel anastomoses.
Therefore, we examined the potential of the COX-2 inhibitor carprofen, widely 
used in veterinary medicine and laboratory animals, to reproducibly induce 
anastomotic leakage in the intestine 
(chapter 4). In twenty rats an anastomosis was constructed in ileum and colon 
carprofen or buprenorphine wa administered (experiment 1). In another 20 rats 
an anastomosis in either ileum or colon was constructed and they were given 
carprofen (experiment 2). Animals were killed after 3 days. In experiment 1, the 
ileal dehiscence rate was 60% in the carprofen group and 0% in the buprenorphine 
group (p=0.0108). Colonic anastomoses in both groups remained patent. In 
experiment 2, the anastomotic leakage rate was 80% in ileum and 0% in colon. 
Anastomotic bursting pressure was also lowered in the carprofen groups. The fact 
that the COX inhibitor carprofen elicts such profound effects in the ileum, though 
not in the colon, should be taken as a further warning that anti-inflammatory 
analgesics may interfere with tissue repair. However, at the same time it offers an 
opportunity to establish a long-wanted model for anastomotic leakage, without 
iatrogenic disruption of the anastomotic integrity. This model provides a means to 
perform much needed translational research on the effectiveness of, for instance, 
peroperative suture line reinforcement (see also chapter 7).
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Future directions
Mostly, in science the outcome of experiments will lead to new questions and new 
experiments. Fresh data always raise new questions. This also goes for the 
experiments and results described here. All data originate from preclinical 
experiments and it remains to be established to what extent they are valid in the 
clinical situation. Thus, in very general terms, clinical validation of the most 
salient facts must certainly be part of future research. In addition, certain results 
also ask for further investigation in preclinical setting.
Our data warrant caution against an abundant and indiscriminate use of NSAIDs 
in the peri-operative period. Three different NSAIDs are shown to interfere, to 
various extent, with anastomotic healing in the intestinal tract. This seems 
especially disturbing in the case of diclofenac, which is used with increasing 
frequency after (fast-track) surgery. Over the last few years incidental clinical 
reports have surfaced on retrospective studies linking the use of NSAIDs to 
anastomotic leakage. The question, whether perioperative use of NSAIDs indeed 
can be a risk factor for anastomotic leakage can only be answered in the setting of 
a randomized controlled clinical trial. Perhaps, such a trial should be preceded by 
experimental studies which focus on our hypothesis that the COX-2 selectivity of 
the drugs decides the degree of interference with anastomotic healing. Next to 
diclofenac and naproxen, other frequently used NSAIDs exhibiting a wide range in 
selectivity for COX-1 and COX-2 should be examined. Also, the role of COX-2 in the 
early repair sequence and its expression during healing should be topics of further 
research. The fact that, in rats, only the ileum seems affected and not the distal 
colon also ask for further study into basal and induced expression of (COX-1 and) 
COX-2 throughout the gastrointestinal tract. In the end, it may well be that this 
line of research would offer enough incentive to change our current use of 
analgetics for postoperative pain relief.
It is obvious and often stated that anastomotic leakage remains a topic worthwhile 
for further study. Its frequency, certainly under ‘high-risk’ conditions, appears 
unacceptable and its consequences can be disastrous. Over the last decades it has 
often been argued that, in order to study anastomotic dehiscence in a preclinical 
setting, one should have an (animal)model at one’s disposal where leakage is the 
primary outcome parameter. However, it can also be argued that wound strength 
is a good measure for the risk for anastomotic leakage to occur and, indeed, by far 
most studies use this as the primary outcome parameter. 
Still, if a model would be available where a patent anastomosis fails with time, it 
would add a much needed, and often wished for, tool. The results of our experiments 
into the effects of NSAIDs, and particularly carprofen, have demonstrated that 
administration of this drug may have the desired effect and cause a patent 
between days 3 and 5. At day 5, the bursting pressure in the fibrin glue group 
remained below than that in the controls, although only significantly (p=0.0138) 
so in the ileum. At day 5, but not at day 7, the wounds in the fibrin glue group 
contained less collagen. Other aspects of microscopic wound architecture appeared 
to be the same. Thus, a certain delay in the recovery of intestinal strength cannot 
be denied, while wound strength during the first 3 days appears unaffected.
Altogether, the available evidence indicates fibrin glue to be not beneficial, and 
at its best irrelevant, to anastomotic healing in the intestine and there is no 
justification for using fibrin glue on patent anastomoses constructed under 
low-risk conditions. Its potential benefit under conditions where chances for 
anastomotic leakage are enhanced needs further investigation.
As described above, the use of carprofen leads to frequent signs of leakage of 
anastomoses in the rat ileum. Therefore, we conducted a study to investigate if 
the use of fibrin glue, or a fibrin coated patch, could protect anastomotic integrity 
in such a model for high-risk anastomoses (chapter 7). 
In 110 rats an anastomosis was constructed in the ileum.  In experiment 1, where 
20 animals were divided over a control and a fibrin glue group, all rats were 
administered carprofen (5mg/kg/day) starting prior to surgery. In experiment 2 
the 90 rats were divided over two groups which received either carprofen  (1.25 
mg/kg/day) starting prior to surgery (group 2A) or starting 24 h after surgery 
(group 2B) in a dosage of 5 mg/kg/day. Both group 2A and 2B were divided into a 
control, a fibrin glue and a fibrin coated patch group, each consisting of 15 animals. 
The animals in experiment 1 and experiment 2A were killed at day 3 and those in 
experiment 2B at day 4 after surgery.
In experiment 1 anastomotic leakage rates, ileus and wound strength did not 
significantly differ between groups. In experiment 2A ileus was significantly more 
frequently present in fibrin glue and the fibrin coated patch group compared to 
the control group (p=0.02 and p<0.001, respectively), but anastomotic leakage rates 
and wound strength did not significantly differ. 
In experiment 2B the bursting pressure on day 4 was significantly lowered in the 
fibrin glue  (p<0.001) and fibrin coated patch group (p<0.01) compared to the 
control group. Anastomotic leakage rates were highest in the fibrin glue group, 
although not significantly so. Protecting anastomotic integrity must remain an 
import goal of ongoing research to lower morbidity and mortality rates. In the 
present model, sealing the high-risk anastomosis with fibrin glue or a fibrin coated 
patch does not lower leakage rates and causes ileus. This suggests that these 
measures should be treated with caution. 
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anastomosis to fail. A goal for immediate follow up should be to determine the 
mechanism and to optimize the model in terms of leakage rates and other outcome 
parameters. Then, it could be used to further study methods that can minimize, 
prevent or postpone (the consequences of) leakage. In this respect, suture line 
reinforcement by (fibrin)glues or surgical tapes warrants further attention.
nederlandse samenvattinG
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Samenvatting
Een lekkende darmanastomose is een relatief veel voorkomende ernstige complicatie 
van gastrointestinale chirurgie die geassocieerd is met een verhoogde morbiditeit 
en mortaliteit. Veel klinische en preklinische studies hebben gepoogd factoren te 
identificeren welke een risico vormen voor ongestoorde genezing van de anastomose. 
Dat naadlekkage nog steeds optreedt als geen van de vermoede risicofactoren 
aanwezig is, illustreert dat er nog veel onbekend is over bijvoorbeeld de invloed van 
veel gebruikte perioperatieve pijnstillers op de genezing van darmanastomosen.
Daarnaast is er een hernieuwde interesse naar de mogelijkheden van het verstevigen 
van de anastomose om naadlekkage en de gevolgen ervan te voorkomen.
De achtergrond voor de studies die zijn gedaan wordt uiteengezet in hoofdstuk 1. 
Alle experimenten zijn uitgevoerd in een diermodel (rat). Binnen ons laboratorium 
bestaat veel ervaring met dit model en het is geschikt gebleken voor het bestuderen 
van de (wond)genezing van darmanastomosen. Primaire uitkomstmaten voor wond- 
genezing zijn wondsterkte, gemeten als barstdruk en trekkracht, en lekkage van 
de anastomose. Daarnaast worden ook de hoeveelheid collageen in de wond en de 
histologische architectuur van de anastomose als parameters voor genezing gebruikt.
Paracetamol wordt zeer veel toegediend voor pijnstilling na een operatieve ingreep. 
Het effect van paracetamol op de wondgenezing is echter nauwelijks onderzocht. 
In hoofdstuk 2 wordt de eerste studie beschreven naar de effecten van paracetamol 
op de vroege genezing van darmanastomosen en de abdominale fascie. In 78 ratten 
werd een anastomose in zowel ileum als colon aangelegd. De ratten werd 
oplosmiddel of, respectievelijk, een lage of een hoge dosis paracetamol (50 or 200 
mg/kg/dag, verdeeld over twee doseringen) toegediend, totdat ze werden gedood 
op dag 3 of 7 na operatie. Voor geen van de onderzochte parameters werd, op dag 3 
of dag 7, een significant verschil gevonden tussen de controle en de paracetamol-
groepen. De wondsterkte van de anastomose en de abdominale fascie nam 
significant toe in alle groepen van dag 3 naar dag 7. Er werden geen verschillen 
gevonden in collageenhoeveelheden en de histologische architectuur van de 
anastomosen. Paracetamol lijkt dan ook geen negatief effect te hebben op de 
wondgenezing van de hier bestudeerde weefsels. Deze studie suggereert dat 
paracetamol veilig kan worden toegediend als postoperatieve pijnstiller na gastro-
intestinale chirurgie.
Naast paracetamol vormen non-steroid anti-inf lammatory drugs (NSAIDs) een 
belangrijk onderdeel van de protocollen voor postoperatieve pijnstilling. Men 
begint echter steeds meer te beseffen dat het gebruik van NSAIDs wellicht 
consequenties kan hebben voor de wondgenezing, met name in de inflammatoire 
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niet in het distale colon, moet als een waarschuwing worden gezien dat anti-inflam-
matoire medicatie mogelijk het wondgenezingsproces kan verstoren. Tegelijkertijd 
biedt het echter de mogelijkheid een lang gezocht model voor naadlekkage te 
ontwikkelen, waarbij er in opzet een patente en intacte naad wordt gemaakt. Dit 
model voorziet in de behoefte om onderzoek te verrichten naar de effectiviteit van 
bijvoorbeeld peroperatieve versteviging van de anastomose. (zie ook hoofdstuk 7).
Hoofdstuk 5 beschrijft meerdere experimenten die zijn gericht op het verder 
karakteriseren van de voornoemde negatieve effecten van carprofen op de vroege 
genezing van de anastomose. In 159 ratten werd een anastomose geconstrueerd in 
het ileum. In experiment 1 werden 84 ratten verdeeld over controle en experimentele 
groepen welke dagelijks hetzij buprenorfine hetzij carprofen kregen toegediend 
en welke werden gedood op dag 1, 2 of 3 na operatie. In experiment 2 werd aan 3 
groepen van 15 ratten dagelijks carprofen toegediend, te beginnen direct na operatie 
of 1 of 2 dagen later. De ratten werden 3 dagen na de start van toediening van 
carprofen gedood.
In experiment 3 werd dagelijks aan 3 groepen van 10 ratten verschillende doseringen 
carprofen toegediend (volledig, half of kwart) direct na operatie. Carprofen 
induceerde al vanaf dag 1 frequent tekenen van naadlekkage, terwijl er in de 
 buprenorfine-groep geen naadlekkage te zien was. Als er met de toediening van 
carprofen 48 uur werd gewacht, was er een significante afname van naadlekkage 
(van 80 naar 20%; p=0.0028). In deze studie was de barstdruk het laagst in de ratten 
waar tekenen van naadlekkage te zien waren.  De aanwezigheid van tekenen van 
naadlekkage ging niet gepaard met afname van de hoeveelheid hydroxyproline of 
een verhoogde activiteit van matrix metalloproteinasen. We kunnen concluderen 
dat carprofen de zeer vroege fase van wondgenezing in het ileum van de rat 
verstoort. Als de rat hier niet aan overlijdt, induceert dit fenomeen op zijn minst 
een verlaagde weerbaarheid tegen eventuele additionele negatieve postoperatieve 
condities. 
Ondanks het gegeven dat de mechanismen die in deze experimenten verantwoordelijk 
zijn voor naadlekkage nog niet volledig ontrafelt zijn, dragen deze resultaten bij aan 
een groeiende bewijslast welke suggereert dat NSAIDs de wondgenezingscascade 
kunnen verstoren.
In theorie lijkt het logisch een soort van afdichting rond de anastomose aan te 
brengen om lekkage te voorkomen. Zeer recent is het wederom benadrukt dat de 
potentiële voordelen van een dergelijke versterking van de anastomose nader 
onderzoek behoeven. Het concept dat fibrinelijm gebruikt kan worden om de 
anastomose te versterken is niet nieuw. Eerder onderzoek heeft echter nog geen 
consistente en betrouwbare data opgeleverd welke de effectiviteit van fibrinelijm 
fase. In hoofdstuk 3 wordt een studie beschreven naar het effect van de NSAIDs 
diclofenac en naproxen. In zowel colon als ileum van 104 ratten werd een anastomose 
aangelegd. De ratten werden verdeeld in groepen die dagelijks diclofenac (4 mg/kg/
dag) of naproxen (10 mg/kg/dag) kregen toegediend vanaf de dag van operatie of 
vanaf 3 dagen na de operatie. De dieren werden gedood op dag 3 of dag 7. 
Naadlekkage in het ileum (p<0.0001) en mortaliteit (p=0.001) waren significant 
verhoogd in de diclofenac-groep. Op dag 7 was de barstdruk in het ileum lager in 
de diclofenac en naproxen-groepen vergeleken met de controle-groep. 
Wanneer diclofenac pas vanaf dag 3 na operatie werd toegediend werd er nauwelijks 
naadlekkage gezien. De colonanastomose en abdominale fascie waren nooit 
aangedaan. Deze studie impliceert dat diclofenac, indien het meteen na de operatie 
wordt toegediend, de genezing van de anastomose in het ileum van de rat sterk 
negatief beïnvloedt. Dit effect wordt ook in mindere mate bij naproxen gezien. Een 
interessante bevinding is dat het uitstellen van het toedienen van de medicatie 
naar dag 3 na operatie deze complicaties voorkomt.
NSAIDs verschillen in hun selectiviteit voor COX-1 en COX-2. Diclofenac wordt 
selectiever bevonden voor COX-2 dan naproxen. Selectieve NSAIDs worden vaak 
geprefereerd omdat wordt verondersteld dat ze minder bijwerken geven. Men moet 
zich echter realiseren dat dit vooral bij chronisch gebruik van belang is. In de 
korte postoperatieve periode is het belangrijker een analgetisch medicijn te kiezen 
dat niet interfereert met de wondgenezing.
Uit eerder werk verricht op ons laboratorium en de data beschreven in hoofdstuk 3 
blijkt dat NSAIDs met een voorkeur voor COX-2 inhibitie juist naadlekkage induceren 
in de dunne darm. Dit suggereert dat een gecontroleerde toediening van een 
geschikt medicijn van deze klasse kan resulteren in reproduceerbare naadlekkage 
zonder excessieve mortaliteit in patente anastomoses in de dunne darm.
Daarom hebben we de mogelijkheden van de COX-2 remmer carprofen, die frequent 
wordt gebruikt in de veterinaire geneeskunde en bij laboratoriumdieren, onderzocht 
met als doel reproduceerbaar naadlekkage te induceren (hoofdstuk 4). In 20 ratten 
werd een anastomose geconstrueerd in zowel ileum als colon en de ratten kregen 
carprofen of buprenorfine als pijnstilling (experiment 1). In experiment 2 werd in 
nog eens 20 ratten een anastomose in het ileum of het colon gemaakt en deze 
ratten kregen carprofen. De dieren werden na 3 dagen gedood. 
In experiment 1 werd in 60% van de anastomoses in het ileum lekkage gezien in 
de carprofen-groep ten opzichte van 0% in de buprenorfine-groep (p=0.0108). De 
anastomosen in het colon waren niet aangedaan. In experiment 2 werd in 80% van 
de anastomoses in het ileum lekkage gezien en bij geen van de anastomosen in het 
colon. De barstdruk was ook verlaagd in de carprofen-groepen. Het feit dat de COX 
remmer carprofen zulke hevige negatieve effecten kan hebben in het ileum, hoewel 
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gezien in de fibrinelijm-groep en in de fibrine gecoate matrix-groep in vergelijking 
tot de controle-groep (respectievelijk p=0.02 en p<0.001), maar incidentie van 
naadlekkage en wondsterkte waren niet verschillend. In experiment 2B was de 
barstdruk op dag 4 significant lager in de fibrinelijm-groep (p<0.001) en fibrine 
gecoate matrix-groep (p<0.01) dan in de controle-groep. In de fibrinelijm-groep 
trad de meeste naadlekkage op, maar dit verschil was niet significant. Beschermen 
van de patente anastomose moet het doel blijven van onderzoek ten einde de 
morbiditeit en mortaliteit te verlagen. In het huidige model is er echter geen 
sprake van verminderde naadlekkage wanneer fibrinelijm of een fibrine gecoate 
matrix rond de anastomose wordt aangebracht. Deze maatregelen veroorzaken 
zelfs ileus. De resultaten suggereren dat het gebruik van dergelijke methoden met 
zorg moeten worden afgewogen. 
Toekomstige onderzoek
In de wetenschap is het vaak zo dat de uitkomsten van experimenten leiden tot 
nieuwe vragen en experimenten. Nieuwe data zorgen altijd voor nieuwe vragen. 
Dit geldt ook voor de experimenten en resultaten die hier zijn beschreven. Alle 
data zijn verzameld uit preklinische experimenten en in hoeverre ze ook gelden in 
de klinische situatie zal nog moeten blijken. Over het algemeen zal klinische 
validatie van de meest opvallende bevindingen zeker onderdeel moeten zijn van 
toekomstig onderzoek. Daarnaast zijn er ook resultaten die verder onderzoek in de 
preklinische setting vragen. 
 
Onze data gebieden dat voorzichtigheid is geboden bij het overdadig toedienen 
van NSAIDs in de periode rond de operatie. Bij drie verschillende NSAIDs wordt 
in meer of mindere mate verstoring van de genezing van de darmanastomose 
aangetoond. Met name diclofenac lijkt dit proces te verstoren, terwijl dit middel 
steeds vaker in de kliniek gebruikt wordt na (snel herstel) operaties. 
In de laatste jaren zijn er incidentele retrospectieve studies verschenen die het 
optreden van naadlekkage lijken te correleren aan het gebruik van NSAIDs. De 
vraag of perioperatief gebruik van NSAIDs inderdaad een risicofactor is voor 
naadlekkage kan alleen worden beantwoord door een gerandomiseerd klinisch 
onderzoek. Misschien zou een dergelijke studie vooraf moeten worden gegaan 
door experimentele studies welke zich concentreren op onze hypothese dat de 
COX-2 selectiviteit van verschillende medicijnen samenhangt met de mate waarin 
wondgenezing van de anastomose wordt verstoord.  Naast diclofenac en naproxen 
zullen ook andere frequent gebruikte NSAIDs met een variatie in COX-1 en COX-2 
selectiviteit moeten worden onderzocht. De rol van COX-2 in de vroege wond - 
genezing en de expressie ervan gedurende genezing moeten eveneens onderwerp 
zijn van verder onderzoek. Het feit dat in ratten alleen het ileum is aangedaan en 
onderbouwen en een indicatie voor het gebruik in de kliniek mogelijk maken. 
Incidentele preklinische data lijken te suggereren dat fibrinelijm aangebracht 
rond de anastomose in het colon de wondsterkte negatief kan beïnvloeden. Daarom 
worden in hoofdstuk 6 de resultaten beschreven van een studie naar het effect 
van aanbrengen van fibrinelijm rond een patente, intacte anastomose. In 108 
ratten werd een anastomose in het ileum en colon aangelegd. In de helft van de 
ratten werd fibrinelijm rond de anastomose aangebracht. De ratten werden op dag 
1, 3, 5 of 7 na operatie gedood. In de experimentele groep werd een voorbijgaande 
ileus in het colon gezien. De trekkracht van de anastomose was gelijk in de controle 
en fibrinelijm-groepen. De barstdruk bleef laag op dag 1 en 3, zonder verschillen 
tussen de groepen. In beide groepen nam de barstdruk fors toe (p<0.001) tussen 
dag 3 en dag 5, zonder significante verschillen tussen de groepen. Op dag 5 was de 
barstdruk van de fibrinelijm-groep lager dan die van de controle-groep, maar dit 
was alleen significant (p=0.0138) in het ileum. Op dag 5 bevatte de anastomosen in 
de fibrinelijm-groep minder collageen dan in de controle-groep. Dit verschil was 
op dag 7 verdwenen. De histologische architectuur was niet verschillend in beide 
groepen. Ondanks een vertraging in herstel van wondsterkte, lijkt de wondsterkte 
in de eerste 3 dagen niet aangedaan. 
Het beschikbare bewijs lijkt niet aan te kunnen tonen dat toepassing van fibrinelijm 
voordelen heeft. In het beste scenario wordt de genezing van de anastomose niet 
negatief te beïnvloed. Het lijkt echter niet zinvol om fibrinelijm aan te brengen om 
een anastomose die wordt aangelegd in een laag risico-situatie. Het potentiële 
voordeel wat fibrinelijm kan bieden in situaties waar de kans op naadlekkage 
verhoogd is behoeft verder onderzoek. 
Zoals hierboven beschreven wordt, leidt het gebruik van carprofen tot het frequent 
voorkomen van naadlekkage in het ileum van de rat. Daarom hebben we bestudeerd 
of het aanbrengen van fibrinelijm, of een fibrine gecoate matrix, de anastomose 
die wordt aangelegd in een dergelijk hoog risico-model tegen naadlekkage kan 
beschermen (hoofdstuk 7). In 110 ratten werd een anastomose in het ileum 
geconstrueerd. In experiment 1 werden 20 ratten verdeeld over een controle en 
een fibrinelijm-groep. Alle ratten kregen carprofen (5mg/kg/dag) vanaf de operatie. 
In experiment 2 werden 90 ratten verdeeld over 2 groepen welke of carprofen (1.25 
mg/kg/dag) kregen toegediend vanaf de operatie (groep 2A) of vanaf 24 uur na 
operatie in een dosering van 5 mg/kg/dag (groep 2B). Zowel groep 2A als groep 2B 
werden verdeeld in een controle, fibrinlijm en een fibrine gecoate matrix-groep 
die elk uit 15 dieren bestonden. De ratten in experiment 1 en 2A werden gedood 
op dag 3 en de ratten in experiment 2B op dag 4 na operatie.
In experiment 1 verschilde de frequentie van naadlekkage en ileus en de wond sterkte 
niet significant tussen de groepen. In experiment 2A werd ileus significant vaker 
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niet het distale colon vraagt om verdere bestudering van de basale en geïnduceerde 
expressie van (COX-1 en) COX-2 in de tractus gastrointestinalis. Uiteindelijk zou het 
zo kunnen zijn dat deze onderzoekslijn genoeg aanwijzingen geeft om ons huidige 
gebruik van postoperatieve pijnstilling te heroverwegen en aan te passen. 
Het is duidelijk en vaak benoemd dat naadlekkage een probleem blijft dat verdere 
bestudering behoeft. De frequentie waarmee deze complicatie optreedt, zeker 
onder hoog risico-omstandigheden, lijkt onacceptabel en de consequenties kunnen 
desastreus zijn. In de laatste tientallen jaren is vaak geponeerd dat, om naadlekkage 
in de preklinische setting adequaat te kunnen onderzoeken, er een (dier)model 
beschikbaar moet zijn waar lekkage de primaire uitkomstmaat is. 
Daarbij moet worden opgemerkt dat ook wondsterkte als een goede maat kan 
worden gezien voor het risico van het optreden voor naadlekkage. Tot op heden 
wordt deze inderdaad vrijwel altijd gebruikt als primaire uitkomstparameter. 
Indien er echter een model beschikbaar zou zijn waar een patente, intacte anastomose 
in de loop van de tijd toch gaat lekken zou dit een gewenst en bruikbaar model 
zijn. De resultaten van de experimenten naar de effecten van NSAIDs, in het bijzonder 
carprofen, laten zien dat het toedienen van dit medicijn dit gewenste effect zou 
kunnen bewerkstelligen.
Een doel van toekomstig onderzoek op korte termijn zou het vaststellen van het 
mechanisme en het optimaliseren van het model in termen van lekkage en andere 
parameters kunnen zijn. Dan zou het model gebruikt kunnen worden om methoden 
te bestuderen die (de consequenties van) naadlekkage kunnen minimaliseren, 
uitstellen of voorkomen. In dit kader zal het versterken van de anastomose door 
(fibrine)lijm of chirurgische tape ook nader moeten worden onderzocht.
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Dankwoord
Het is onmogelijk om iedereen te bedanken die heeft bijgedragen aan dit proefschrfit. 
Enkele personen verdienen een bijzonder woord van dank.
Geachte promotor, beste professor van Laarhoven
U heeft mij de kans gegeven om fulltime met dit onderzoek van start te gaan. In deze 
periode heb ik samen met Thijs de basis gelegd. Mede dankzij uw betrokkenheid, 
heldere doelstellingen, scherpe opmerkingen en deadlines is het onderzoek binnen 
drie jaar uitgebloeid tot een proefschrift, wie had dat gedacht! Hartelijk dank voor 
het vertrouwen dat u in mij stelt, ik kijk uit naar onze samenwerking tijdens de 
rest van mijn opleiding tot chirurg.
Geachte copromotor, beste Thijs
Zonder jou was dit proefschrift er niet geweest. Ik heb veel van jou, je gevreesde 
digitale rode pen en niet in de laatste plaats van onze gesprekken die soms ook 
over onderzoek gingen mogen leren. Ik heb veel respect voor de manier waarop jij 
het onderzoeklaboratorium heelkunde hebt geleid en hoop dat je nu kan gaan 
genieten van je welverdiende pensioen, het is een eer je laatste promovenda te 
mogen zijn.
Geachte leden van de manuscript commissie
Ik dank prof. Schalkwijk, prof. Feitz en dr. de Hingh hartelijk voor het beoordelen 
van het manuscript.
Ben de Man
Jij hebt mij de anastomose in de rat leren leggen, de basis van dit onderzoek. Helaas 
mocht je mijn promotie niet meer meemaken. Je wordt nog elke dag gemist op het lab.
Roger Lomme
De stille, onmisbare en betrouwbare kracht achter dit boekje, maar ook achter het 
onderzoeklaboratorium heelkunde. Bedankt voor al je hulp bij analyses, grafieken, 
experimenten met paverpol, maar vooral voor de fijne samenwerking tijdens al die 
experimenten op het dierenlaboratorium. En natuurlijk bedankt voor de monchou 
taart en de stipte koffietijd.
Biotechnici en dierverzorgers van het Centraal Dierenlaboratorium
Hartelijk dank voor de praktische ondersteuning bij mijn experimenten, zorg voor 
de ratten en behulpzaamheid. Een speciaal woord van dank voor Daphne Reijnen: 
één belletje of mailtje en het was altijd goed geregeld.
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Het onderzoekshok
In deze ruimte heb ik met veel mensen samengewerkt, koffie gedronken, gevloekt, 
ideeën uitgewisseld, taart gegeten ter ere van publicaties en een borrel gedronken 
bij tegenslagen of gewoon omdat het vrijdag was. In het bijzonder wil ik toch Guus, 
Ronald en Sharonne noemen en bedanken voor de mooie tijd die we hebben gehad 
met vliegtuigjes landen, organiseren van de chirurgencup, het beplakken van het 
plafond en het uithalen van de mooiste grappen: het was een welkome afwisseling 
op de onderzoeksperikelen. Mogen jullie boekjes snel volgen!
Collega’s assistenten Heelkunde
Samenwerken met jullie maakt de opleiding nog leuker! Bedankt voor alle promotie 
tips en -tricks en voorbeeldproefschriften.
Mijn familie, vriendinnen en vrienden
Jullie zijn me ontzettend dierbaar. Het boek is af en dat betekent meer tijd voor 
jullie. Kom en vier het mee!
Oma, kijk je mee vanaf je wolkje?
Paranimfen
Sharonne, dat jij mijn paranimf bent is al heel lang geleden vast komen te staan. 
Van springerige en nieuwsgierige collega tot vriendin. Werken als zaalarts, onder - 
zoeken, solliciteren, opleiding, congressen, cursussen, huizen zoeken, eten, winkelen: 
(bijna) alles doen wij samen. Gelukkig sta je ook vandaag naast mij. Ik ben heel 
benieuwd naar wat we nog meer samen gaan beleven.
Jacquelijn, onze band is sterk en betekent veel voor mij. Ik ben ontzettend trots op 
wat mijn kleine zus allemaal al bereikt heeft en ik kijk uit naar wat de toekomst je 
zal brengen. Ik hoop dat je vandaag ook trots op mij bent en ik vind het ontzettend 
fijn dat je vandaag aan mijn zijde staat.
Mijn ouders
Mam, pap: ik weet dat jullie zullen glunderen op de eerste rij! Wees vooral ook trots 
op jezelf, jullie hebben de basis zelf gelegd, ook voor dit proefschrift. Onvoorwaardelijk 
scheppen jullie de voorwaarden om het beste uit mijzelf te halen, dat ervaar ik als 
zeer bijzonder. Ons gezin voelt nog altijd als een warme deken, dank jullie wel.
Casper, dit boekje is niet compleet zonder een woord voor jou. Jouw bijdrage aan 
dit proefschrift is groter dan je denkt. Jij biedt een luisterend oor en weet me altijd 
weer aan het lachen te maken. Ik kijk uit naar onze toekomst samen.

